The Peter Attia Drive - January 19, 2026


#380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats? | Layne Norton, Ph.D.


Episode Stats

Length

2 hours and 7 minutes

Words per Minute

176.90482

Word Count

22,575

Sentence Count

1,313

Misogynist Sentences

1

Hate Speech Sentences

9


Summary

Summaries generated with gmurro/bart-large-finetuned-filtered-spotify-podcast-summ .

Lane Norton is a nutrition scientist and accomplished power athlete, and a very evidence-based thinker in the space of diet and metabolic health. In this episode, we discuss the role of evidence in the seed oil debate, and how it relates to modern dietary choices.

Transcript

Transcript generated with Whisper (turbo).
Misogyny classifications generated with MilaNLProc/bert-base-uncased-ear-misogyny .
Hate speech classifications generated with facebook/roberta-hate-speech-dynabench-r4-target .
00:00:00.000 Hey, everyone. Welcome to the Drive podcast. I'm your host, Peter Atiyah. This podcast,
00:00:16.540 my website, and my weekly newsletter all focus on the goal of translating the science of longevity
00:00:21.520 into something accessible for everyone. Our goal is to provide the best content in health and
00:00:26.720 wellness, and we've established a great team of analysts to make this happen. It is extremely
00:00:31.660 important to me to provide all of this content without relying on paid ads. To do this, our work
00:00:36.960 is made entirely possible by our members, and in return, we offer exclusive member-only content
00:00:42.700 and benefits above and beyond what is available for free. If you want to take your knowledge of
00:00:47.940 this space to the next level, it's our goal to ensure members get back much more than the price
00:00:53.200 of a subscription. If you want to learn more about the benefits of our premium membership,
00:00:58.000 head over to peteratiyahmd.com forward slash subscribe.
00:01:04.140 My guest this week is Lane Norton. Lane is a nutrition scientist and accomplished power athlete
00:01:10.300 and a very evidence-based thinker in the space of diet and metabolic health. And while Lane's been
00:01:16.680 on the podcast many times, today's episode is a little bit different from sort of the usual podcast
00:01:21.680 dynamic. Now, originally, this was supposed to be our first in a series that we've been toying with,
00:01:29.380 which is kind of a debate episode. I've talked about these a little bit on other podcasts,
00:01:33.580 but the long and short of it is I wanted to do a debate that was going to be incredibly rigorous.
00:01:39.340 In fairness, I've never really seen a podcast debate that was anything other than nonsense,
00:01:45.520 if I'm being blunt. And the reason is the format is basically impossible because people can make up
00:01:52.760 anything they want. They can cite anything they want out of context. And no human has the capacity
00:01:57.900 to know the entire body of literature up front. And therefore, it's very difficult to counter claims
00:02:04.720 regardless of whatever the topic of discussion is. I've just never found this appealing. And so
00:02:09.080 over the past year, we've been sort of noodling this idea of, well, what if we ran a debate like a
00:02:14.280 court case? And of course, in a court case, everybody has to sort of present their evidence
00:02:18.920 up front during a process called discovery. And that allows both sides to view the evidence of
00:02:25.820 the opposing arguments along with their own arguments in equal time. That way, there's no
00:02:30.820 ambiguity about what's being presented. We came up with an idea, which was we were going to start with
00:02:35.620 this first topic, which is to be the seed oil debate, which I'll clarify a little bit more in a
00:02:40.160 moment. And the idea was, we'll take two very thoughtful individuals who have opposing views.
00:02:45.580 And we did just that. So Lane was on the side of the argument, which was that seed oils are not
00:02:50.940 harmful. We had an individual who took the opposite point of view on that. The idea was that Lane and
00:02:57.280 this other individual would share all of the information that they plan to present with our team and with
00:03:03.580 each other. And that I would serve really here as a moderator of this discussion. And my research team
00:03:09.540 would serve as the fact checkers and that you as the public would basically serve as the jury to my
00:03:15.880 judge. However, the individual on the other side of this argument, for reasons that I'm not entirely
00:03:21.060 clear, decided that they just didn't want to do this. And we felt that it was still a worthwhile topic
00:03:26.080 to explore. And while the format of today's podcast is, in my view, not as potentially interesting as
00:03:33.680 it would have been had we done the original debate, we still think that it brought a lot of value. So
00:03:37.140 what I did was I kind of attempted to steel man the argument against seed oils and therefore allow
00:03:44.100 Lane to represent the pro-seed oil position for why seed oils may or may not be harmful when consumed
00:03:51.480 in isocaloric quantities relative to other fatty acids. That really is kind of the jugular question
00:03:57.320 here, which is, I don't think anybody would dispute that consuming excess anything is harmful. So
00:04:03.220 consuming excess calories in the form of seed oils versus monounsaturated fats versus polyunsaturated
00:04:07.780 fats versus carbohydrates, probably not many people are going to debate the downside of that. But what we
00:04:12.680 were really trying to understand is, is there something that under even isocaloric conditions would make
00:04:17.640 seed oils particularly metabolically harmful. So in this episode, we're going to discuss the role of
00:04:23.660 bias, evidence evaluation, and scientific interpretation as a lead into this, the historical
00:04:28.180 randomized control trials that shape the seed oil conversation, the mechanistic biology of LDL
00:04:34.560 oxidation and atherosclerosis, which is central to this argument, or at least one of the arguments,
00:04:39.260 the methods of oil processing and the chemistry behind modern seed oils, how evolutionary and ancestral
00:04:45.740 arguments fit into these nutritional debates, the relationship between seed oils, ultra processed
00:04:50.200 foods, and modern dietary patterns, the broader lifestyle factors that influence cardiometabolic
00:04:55.640 health, and then ultimately practical considerations around dietary fats, cooking oils, and real world
00:05:00.420 food choices. So in the end, I think we salvaged a lot of hard work that had gone into the preparation
00:05:07.040 for the debate over the course of a year. And ultimately, I think you're going to find a lot of value in
00:05:12.280 this. So without further delay, please enjoy my conversation with Lane Norton.
00:05:21.340 Lane, thank you for making another trip out to Austin.
00:05:24.020 Always. Pleasure to be here.
00:05:25.700 Okay. This is going to be a kind of a different episode. So I'm going to set this up and we're
00:05:29.960 going to give it a shot. So originally we were planning to do this as our inaugural debate series.
00:05:36.400 People have heard me talk a little bit about how I desired to do a debate series, which was to have
00:05:42.860 two people on who had opposing views on a topic. But I've been very vocal of my criticism of debates
00:05:49.840 on podcasts in that I think I could charitably call them useless, which is to say anybody can sort
00:05:56.020 of say anything. And in real time, it's almost impossible to verify what people are saying.
00:06:01.840 And it's not to say that people are necessarily lying. I think it's that people are maybe taking
00:06:07.020 liberal interpretations or not interpreting things the same way. And it would be much more
00:06:11.440 valuable if everybody could be looking at the same thing. So anyway, we had this whole idea where we
00:06:16.820 were going to have two people that were going to pre-submit all of their evidence to me and my
00:06:24.240 analysts, so the entire research team. And everybody was going to agree upfront what the papers were,
00:06:31.600 what the questions were that we were asking, what the data were. And during the process of the
00:06:36.940 debate, people could only reference things that were pre-submitted. In other words, we were going
00:06:41.400 to make it feel a lot like a courtroom. And I say that through the lens of we have a process in court
00:06:46.920 where you have discovery and the opposing lawyers have to submit everything. So this idea made a ton of
00:06:52.160 sense. My role was really to play judge, not jury. The public, the people listening to this would be the
00:06:57.520 jury. They would ultimately be the ones that would decide. And the first topic we're going to focus
00:07:02.000 on was the one we're going to talk about today, which is seed oils. How long did we spend on this?
00:07:05.960 About nine months, a year maybe?
00:07:07.180 Oh, I think it was over a year when we started talking about it.
00:07:08.960 So we identified you as the person who would speak to the argument that seed oils are not uniquely
00:07:15.600 harmful. We identified another individual who seemed incredibly qualified to speak to the other
00:07:20.840 side of this debate, which is to say that seed oils do pose a unique nutritional risk. And for
00:07:27.820 reasons I honestly don't even remember, that individual at some point just decided they didn't
00:07:31.600 want to do it. I think there was some concern that my personal view leaned more towards the side
00:07:38.900 that seed oils are probably not that harmful. I always am pretty vocal about my biases and I was
00:07:44.080 very vocal about stating, I don't really see something here, guys. But I was also clear to point out
00:07:48.620 that I'm simply the judge and not the jury. And ultimately the jury decides, and they're going
00:07:52.000 to also decide if I can be a fair judge. Nevertheless, the person decided not to do
00:07:55.520 this. And that left us asking the question, well, it is still a topic that people care about. And
00:08:01.120 therefore we view ourselves on this podcast as kind of the authority about going really deep on topics
00:08:06.820 that matter. So we thought we would do it anyway. However, we are going to do this a little
00:08:10.980 different than a normal podcast. Instead of just a regular interview, I am actually going to make my best
00:08:17.380 attempt to steel man the case for the other guest who is not here. Because again, in the process of
00:08:24.220 whatever we spent a year together, I did come to better understand the arguments for why a person
00:08:31.020 would think seed oils are uniquely harmful as a class of fatty acids. So with all of that said,
00:08:37.840 would you like to add anything before we jump into this?
00:08:40.960 I think that when speaking to bias, I think it's important to point out that everyone has bias.
00:08:46.640 Everyone has personal beliefs they developed. And that is just a human characteristic. There's no
00:08:52.760 way to get rid of that. I have my own personal beliefs. But what I will say is, I'm very upfront
00:08:59.080 about my biases. If we're on a topic where I have a different opinion than perhaps the consensus of the
00:09:05.480 literature or some other experts who I do consider to be good evidence-based experts, and I have a
00:09:11.080 different opinion, I will say, hey, look, this could be my bias showing here. Or I have a bias towards
00:09:16.360 this. I understand what this literature says. Here's why I think that maybe it doesn't capture it all
00:09:22.380 right now. And I think that that's about as best as you can do. And one of the things I told a friend the
00:09:28.700 other day was, people think that funding or money is by far the biggest driver of people essentially
00:09:37.400 like not sticking with the evidence. And I would say that in some cases, that's true. But I think
00:09:43.420 that personal beliefs are actually just as powerful, if not more powerful. I mean, look at how many
00:09:48.020 people spend hours online arguing over politics that get zero money from arguing about politics.
00:09:52.900 I just think that the current day and age with social media, with clickbait, that things are very
00:09:59.120 information siloed, and there can be a lot of talking past each other. And I hope today, what we can do
00:10:06.100 is present this evidence. And I will acknowledge where I think that there is something really there.
00:10:13.580 And then I will also explain why I think overall, my view is accurate and in line with the best data
00:10:19.900 available. And just to be clear, upfront, if anybody has a bias against seed oils, it probably should be
00:10:27.560 me. I came from a lab that was very much in line with the lower carb way of thinking of maybe saturated
00:10:37.720 fat isn't as bad as we thought. Maybe LDL doesn't matter. And I got into graduate school in 2004,
00:10:44.040 when that was a pretty popular idea that, okay, well, maybe it's not just saturated fat, LDL. Maybe
00:10:50.140 it's the particle size, the oxidation status, LDL to HDL ratio. And what I'll tell you is I said those
00:10:56.900 things for a long time and eventually changed my mind with the evidence. And just to point out one
00:11:02.800 more thing, my research was funded. I got money from the National Dairy Council, the National Cattlemen's
00:11:09.000 Beef Association, and the Egg Board. I'm painting with a broad brush, but I would say most of the
00:11:13.960 anti, the very, very rigorous anti-seed oil people tend to err on the side of either low-carb,
00:11:21.360 animal-based, or carnivore. And if anybody has a bias towards high-quality animal protein, it's me.
00:11:26.960 So I just want to start there and say that I think a lot of people, when the research conflicts with
00:11:33.620 whatever their viewpoint is, they immediately jump to funding source or think that there's something
00:11:38.160 nefarious going on. And what I will say is the scientific method is perfect. It is a perfect
00:11:44.480 method, but it is done by people who are not. And that is why it is so important to look at the
00:11:50.880 overall consensus of the evidence and looking at the different converging lines of evidence, which is
00:11:58.160 something you'll probably hear me talk about a lot today, because I do think there's a lot of converging
00:12:02.040 lines of evidence here. And that can give us a relatively strong or weak amount of confidence in how
00:12:07.920 accurate something is or a statement is. And so I just want to put all that out there, because when you're
00:12:13.520 looking through scientific research or you're scrolling social media, if you have a bias towards
00:12:18.740 something, you can always find a study or phrase something in a way that supports whatever you wish
00:12:25.280 to be true. And so that is why it's important. I think people like what you and I do, which is trying
00:12:31.880 to cut through that noise that other people who aren't equipped to read research simply can't do.
00:12:37.720 I'm going to tell you what I've heard as the four main arguments for why seed oils should be viewed as
00:12:45.740 potentially harmful. And we're going to kind of talk through these, not necessarily in this order,
00:12:49.760 but I'm going to kind of go through these. One comes down to the mortality literature on some
00:12:55.360 of the large RCTs. We're going to talk about two in particular. In other words, when we go back and
00:13:02.200 look at the literature, particularly in the era when people began to appreciate that saturated fat
00:13:09.020 raised, at the time it was total cholesterol, eventually when it got fractionated, it became
00:13:14.020 another subset of that called LDL cholesterol. We saw the association between LDL cholesterol and
00:13:19.760 ASCBD. The question became, hey, can we substitute something else for saturated fat, think margarine
00:13:26.900 versus butter, to lower cholesterol? So a couple of these studies were done and these studies,
00:13:33.120 while lowering cholesterol, did not lower mortality. We're going to talk about that. We're then going
00:13:37.840 to get into some really mechanistic stuff and talk about LDL through the lens of oxidation. You alluded
00:13:43.820 to this a little bit with your change in thinking around LDL particle size, but this goes kind of a step
00:13:48.160 further than just particle size. We get into the really granular biochemistry of what is happening
00:13:53.320 to an LDL particle that renders it pathologic versus maybe not so much. We're then going to talk
00:13:59.020 a little bit about not just the seed oil per se, but the industrialization of how a seed oil is refined.
00:14:06.660 In other words, is there something about the process of making a seed oil commercially that introduces
00:14:13.520 something that's harmful as a byproduct? And then finally, we're going to talk about this from maybe
00:14:18.220 an evolutionary or first principles perspective, which is, look, if we were having this discussion
00:14:22.920 a hundred years ago, there were no seed oils and people were a lot healthier. So maybe the
00:14:27.800 introduction of seed oils should be viewed as potentially problematic. So let's kind of start
00:14:31.800 with the Minnesota Heart Study. So I've talked about the Minnesota Heart Study before. This is a study
00:14:37.420 that took place in the 1960s. I believe it ran seven years-ish. It's notable because it was carried out
00:14:47.440 in an environment that would be very difficult to do today. It's very difficult to do long-term
00:14:52.480 nutritional studies with complete control over what your subjects eat. And yet that is essentially what
00:14:58.180 this study was able to do because it was carried out in institutionalized patients. So these were
00:15:03.240 mentally institutionalized patients, they were in patients in a hospital. And the experimental design
00:15:10.860 was quite elegant, which is the subjects were divided into two groups. One group was given a diet that was
00:15:20.100 higher in saturated fat. The other group was given a diet that was lower in saturated fat, but had an
00:15:26.440 isocaloric substitution of polyunsaturated fat. I believe it was mostly linoleic acid that made the
00:15:32.980 substitution. So in other words, you can think of this as substituting saturated fat like butter,
00:15:38.180 lard, meat for other sources. But the oils would, of course, then be the canolas, the safflower,
00:15:44.420 sunflowers, things like that. Yeah, I think in MCE, it was mostly corn oil and then margarine.
00:15:48.440 Yep. Now, here's what was really interesting, Lane. This study completed in, I believe, 1973.
00:15:56.400 So I think it ran from 66 to 73. I think that was the seven years of the study.
00:16:01.100 And the study found that indeed, the total cholesterol of the patients on the higher
00:16:08.820 polyunsaturated fat diet, again, this was isocaloric. It wasn't like we were playing
00:16:13.220 tricks with calories. No, no, no. This was, they were getting the same amounts of calories from
00:16:17.400 the macros even. It was just, we were substituting saturated fat for polyunsaturated fat. The patients
00:16:22.460 on the low saturated fat diet had a significant reduction in total cholesterol. At the time,
00:16:27.160 that was the only tool you had at their disposal. You didn't even have LDL cholesterol, let alone
00:16:31.760 APOB or particle size or any of that stuff. But you saw that total cholesterol went down.
00:16:36.080 Interestingly, and much to the surprise of the investigators, mortality did not.
00:16:41.120 This was such a surprise to the experimenters that they chose not to publish the results of
00:16:46.220 this study for another, I believe, 13 years. So the Minnesota Heart Experiment or the Coronary
00:16:52.080 Minnesota, I forget, there were several different names for it, but this study was not published
00:16:55.020 until the 80s. But as someone trying to make the case that there's got to be something wrong with
00:16:59.860 polyunsaturated fats, how could we otherwise explain that there was no improvement in mortality
00:17:05.320 despite the fact that total cholesterol went down? And total cholesterol went down quite a bit.
00:17:09.620 We don't have the data to say if it was atherogenic particles that went down, but given the magnitude
00:17:14.920 by which it went down, you have to assume at least the fraction of LDL cholesterol went down with
00:17:19.240 it, even if HDL cholesterol went down with it as well. So let's maybe start with that study
00:17:23.900 and say, doesn't that at least suggest that there could be something nefarious about
00:17:27.900 the substitution of lard to those polyunsaturated fats?
00:17:31.740 Yeah. And this is probably the single most popular study that gets cited by people who are
00:17:36.760 making the case that polyunsaturated fats are actually bad for you compared to saturated fat.
00:17:41.380 I want to be really clear. When I make any criticisms of this study, I think it was a very well-designed
00:17:46.220 study for the tools they had at the time and what they knew at the time. And so it's always easy to
00:17:51.240 Monday morning quarterback these things. But I think it was a very well-designed study. The big
00:17:56.380 takeaway was for every, I can't remember exactly the number, I think it was a 30 milligram per
00:18:02.760 deciliter decrease in cholesterol, total cholesterol, that there was like around a 20% increase in
00:18:09.360 mortality.
00:18:10.660 22%.
00:18:11.240 Yeah. So the biggest thing that I'm going to say right off the bat that really confounds all these
00:18:17.500 outcomes is the inclusion of trans fats. So the polyunsaturated fat group, they were getting
00:18:23.440 quite a bit of their polyunsaturated fats from margarine. Margarine at the time was around 25 to
00:18:31.140 40% trans fats. And we know that trans fats are absolutely atherogenic.
00:18:38.460 Can we pause for a minute? I maybe should have done this earlier. We should probably tell people
00:18:43.160 the difference between a saturated fat, a monounsaturated fat, a polyunsaturated fat,
00:18:47.060 and a trans fat as a subset of polyunsaturated fats. Let's go one-on-one just to speed this up.
00:18:52.900 A saturated fat is a hydrocarbon where every bond is saturated. That means there are no double bonds.
00:19:01.800 So every carbon is attached to another carbon, but it has two hydrogens on it. They can swiggle around
00:19:08.540 and that gives it unique properties. So one of the properties of a saturated fat is it is more likely
00:19:15.900 to be solid at room temperature. There are a whole bunch of reasons that are going to come up later
00:19:20.560 when we talk about why saturated fat plays a role in cardiovascular disease through its impact on LDL
00:19:28.260 receptors and cholesterol synthesis. But that's what a saturated fat is. So then tell us what a monounsaturated
00:19:34.020 fat is. So a monounsaturated fat means there is one double bond in the fatty acid chain.
00:19:40.380 Important to point out when it comes to these double bonds and why this probably makes a difference
00:19:44.820 is it changes the fluidity of these membranes because fatty acids and lipoproteins in particular,
00:19:52.860 they're not just like individual fats. They're arranged into what are called micelles,
00:19:58.140 which basically the polar head of the fatty acid is on the outside and then the inside you have all
00:20:03.340 the fatty acid tails. And the reason for that, of course, is that if it wasn't that way, they could
00:20:08.200 never travel around our body because to travel through the medium of our blood, you have to be
00:20:14.620 able to be repelling water on the inside, hydrophobic, while being attracted to water, hydrophilic on the
00:20:20.740 outside. Correct. So you have all these tails kind of pointing towards the center. And then if you think
00:20:26.400 about even on cells, the phospholipid bilayer, the tails are pointing towards each other. And for natural
00:20:32.480 unsaturated fats, like monounsaturated fats or polyunsaturated fats, most of those double bonds
00:20:38.340 are what are called cis double bonds. And I don't want to get too far into the biochemistry of it,
00:20:42.680 but essentially, if you have a cis double bond, it puts a kink in the fatty acid tail. If you have a
00:20:47.900 trans double bond, it doesn't change it. It still essentially looks like a saturated fat in terms
00:20:52.680 of structure besides the double bond. And it's actually easy to picture that. I almost wish I brought
00:20:58.060 a chalkboard to draw on. But anybody who's taken a biochemistry class will remember this. But a
00:21:02.800 cis double bond forces the two carbons up or down, but they are on the same side of the double bond.
00:21:09.460 So that's the real kink. Whereas a trans double bond, you have a carbon here, a double bond, and
00:21:15.840 then the other carbon is here. That stays much straighter than if you force the kink up or down.
00:21:21.360 And as we're going to talk about later when it comes to like LDL aggregation and whatnot,
00:21:26.420 the actual membrane fluidity is actually very important when it comes to the progression of
00:21:32.680 cardiovascular disease. So the membranes and the fatty acid composition of these lipoproteins
00:21:39.200 actually becomes very important. And it's very important to keep that in mind. But when we're
00:21:44.380 talking about unsaturated fat, it's important to point out that trans fats are very unique
00:21:49.820 in terms of the research literature very clearly showing an atherogenic effect.
00:21:55.940 Yeah. And the atherogenic effect of trans fats was so significant that they have effectively been
00:22:02.160 banned by the FDA. It's also important to understand how they came about. When the belief
00:22:06.960 and realization around saturated fats, which have been, I think, probably over demonized historically,
00:22:13.820 when that took place, food makers looked for a substitute. And you brought up an interesting
00:22:19.440 point a moment ago, which is if you have a trans fat, you can have something that is not saturated,
00:22:27.040 but behaves as saturated. So if you think of one of our favorite saturated products, it's butter.
00:22:32.700 Of course, as maybe we will talk about later, there's no food that is purely one thing. So it's not like
00:22:38.720 butter is just saturated fat. In fact, it's probably made up of mono and polyunsaturated fats,
00:22:44.600 if my memory serves correctly, as is even the fattiest ribeye. And actually has some natural
00:22:49.100 trans fats in it as well. Yeah. Low, low amounts. But what makes butter appealing is that it is solid
00:22:54.020 at room temperature. So in an effort to create something that looked, felt, tasted, and behaved
00:23:02.340 like butter, and we were going to deprive you of saturated fat, we had to put in something that at least
00:23:08.080 behaved like saturated fat. So when that margarine that was made up of high amounts, 25% is really
00:23:14.080 high, 25% of that is trans fats, initially thought that was a win because you got the benefit of
00:23:21.120 solid at room temperature. It was only after a few years we realized, actually, this was creating
00:23:26.600 far more heart disease than we were seeing even with saturated fat.
00:23:30.580 And part of that is likely because, and again, this we'll talk about in a little bit,
00:23:34.320 it makes the membrane very rigid because those fatty acid tails can get packed in tighter with
00:23:40.640 saturated fat and trans fat. Whereas when you have those kinks with mono and polyunsaturated fats,
00:23:46.180 it essentially creates space in the membrane. And that is actually very critical in terms of
00:23:52.920 particle recognition by the LDL receptor and also aggregation. But we'll get into that a little bit
00:23:58.640 later. So not only do you have trans fats being able to be packed into lipoproteins in a similar
00:24:05.340 way as saturated fat, but now they have a double bond that can be oxidized as well. So you're getting
00:24:10.020 kind of the worst of both worlds with trans fats.
00:24:13.540 So do we know how much trans fats was consumed by the low saturated fat group in the Minnesota
00:24:20.200 coronary experiment?
00:24:21.600 So as far as I understand, we don't have the specific numbers. We just know that it was likely
00:24:26.120 a significant portion of the polyunsaturated fat based on they essentially got a lot of their
00:24:31.560 polyunsaturated fats from either corn oil or margarine. Now, as far as I know, we don't know
00:24:37.520 the exact composition of each.
00:24:40.200 Was Chris Ramsden at the NIH, who I believe did a re-evaluation of this, was he able ever to identify
00:24:46.760 the raw data on that?
00:24:48.640 I'm not sure to be quite honest with you. I didn't see it anywhere. Maybe if people smarter than me are
00:24:53.140 watching or are familiar with it, I would love to know if they did. I do know there's some other
00:24:58.080 studies where they kind of looked at dietary adherence by looking at LDL in the blood or looking
00:25:06.480 at like linoleic acid incorporation into lipoproteins. But as far as this specific study, I don't think
00:25:13.060 they did. We have to remember, as you said, this study started in 1966. So this was very shortly
00:25:18.780 after it was identified and accepted that saturated fat raised cholesterol and that that seemed to have
00:25:26.080 a pretty strong association with heart disease. So when it came to doing this study, they had no reason
00:25:31.800 to suspect that these trans fats were going to be uniquely deleterious. And the other thing that's I think
00:25:39.440 important to point out, two things are important to point out with the MCE. The second is that during the
00:25:45.240 time that this study was going on, I think laws changed where people who were in psychiatric wards
00:25:50.920 could just check themselves out. And so many of the people in this study were not continuous. In fact,
00:25:57.180 it kind of threw a wrench in the researcher's protocol because I think they had originally planned that
00:26:01.840 these people were going to be continuously housed in these psychiatric wards for the duration of the
00:26:08.020 study. So now you've got another confounder where, okay, they're going in for a period of time and now
00:26:13.840 they're coming out and we don't know what they're consuming while they're out. Now, what I would say
00:26:18.540 if I was going to make a counter argument to that is, well, this is why randomization is important
00:26:23.340 because the likelihood is, okay, if they're changing what they're eating while they're out,
00:26:27.440 it should affect both. Yeah, it's probably equally distributed. So I think that's a far less
00:26:31.940 significant criticism compared to the inclusion of trans fats. And then I think the other thing that's
00:26:38.320 important to point out is it's really hard to do very long RCTs in humans. And this is something
00:26:45.340 uniquely difficult when you're trying to do cardiovascular disease research with hard endpoints
00:26:51.420 because cardiovascular disease is not something that develops in a couple of years.
00:26:56.020 It develops over the course of decades. And so Peter, for example, what I like to compare it to is
00:27:01.400 investing. If you and I start investing, same time, and I get into a mutual fund that on average over
00:27:09.040 the course of let's say 40 years gets me a 9% return and you invest in something that gets 8.5%.
00:27:15.160 If we look a couple of years out, there's really not going to be that much difference. I mean,
00:27:20.100 statistically in terms of significance, probably won't be a significant difference. But if we look 40
00:27:25.460 years out, there's going to be a major difference. It's important to understand that we get into the
00:27:30.500 mechanisms of LDL cholesterol. This is a total lifetime exposure risk. And so when you have
00:27:37.420 people coming in who we don't know what their baseline LDL was, because now if we were doing
00:27:43.620 this experiment, what would probably happen is you would randomize the groups based on their baseline LDL
00:27:49.200 or based on some other marker, maybe calcium score, whatever it is, so that you can have some degree of
00:27:56.080 confidence that you don't have differences at baseline. But they didn't know any of this stuff
00:28:00.840 back then. They didn't have those tools available to them. And so I think it's also important to
00:28:05.120 point out when you're looking at these studies where I think the average follow-up time in this
00:28:08.800 study was about one to two years. That's a pretty short period of time to actually see any real
00:28:15.060 differences in progression of cardiovascular disease and to try and actually find hard endpoints.
00:28:20.980 And as we'll talk about here with some of these other studies, the overall number of deaths are
00:28:25.860 very, very low, even to the point in one trial, like the corn oil trial.
00:28:30.460 Let's talk about that trial, because I was going to say, to get around your point about duration,
00:28:35.340 the Sydney heart study, which is the one you're referring to, attempts to solve this. So it was a
00:28:40.460 much smaller study than the Minnesota coronary experiment, which had nearly 9,000 subjects. This one had
00:28:45.740 a little under 500 subjects, but they were selected to be very high risk. So each of these men had just
00:28:53.300 suffered an MI. So you took a group of men who had just suffered an MI, but they were in the fortunate
00:28:59.980 group at the time who didn't die. And remember, back at the time of the Sydney heart study, you were
00:29:06.060 most likely to die from a heart attack. So you're already pre-selected to be pretty lucky. You haven't
00:29:12.060 died, but your risk is now very, very high. The baseline characteristics of this group were as
00:29:17.920 follows. Their baseline saturated fat intake was 16% of total calories. Their PUFA intake,
00:29:25.080 that's polyunsaturated fat intake, 6%. So the instruction set for the intervention group,
00:29:32.280 they were randomized. The low saturated fat group was instructed to increase PUFA to 15%
00:29:37.400 and reduce saturated fat to 10%. Now that's not draconian, but of course, these people,
00:29:44.580 they were not housed. The manner in which they were doing this was basically through
00:29:49.600 safflower oil and safflower margarine. And let's talk about what happened. So in this study,
00:29:57.420 there was a higher mortality in the control group, meaning the group that stayed on the saturated fat,
00:30:03.660 and it was 32% versus 20% at three years, which again, it's good in a bad way. It's good that you
00:30:10.020 can see a high mortality in three years because you've started with such a sick group. So again,
00:30:15.060 this would at least suggest that that group that lowered saturated fat, raised polyunsaturated fat,
00:30:20.520 they had a higher mortality risk in a short period of time. It could suggest that there's something
00:30:25.680 wrong with the safflower oil. Yeah. And important to point out, a lot of anti-seed oil people
00:30:30.780 will specifically talk about linoleic acid and safflower oil is very high in linoleic acid.
00:30:37.140 So the strengths of this study, it was longer, like you talked about, and these were people who
00:30:43.780 already had cardiovascular disease. So the likelihood that you could see more hard endpoints
00:30:49.740 during the duration of the study was higher. Now that also comes with the opposite side of the coin,
00:30:55.240 which is they already had a cardiovascular disease event. They've already had a lifetime
00:30:59.200 of accumulation of plaque. So how much difference can you really make on this truck that's already
00:31:07.220 rolling down the hill? Again, the main criticism of the study, which I think is quite frankly,
00:31:12.460 the biggest confounder with these trials is the inclusion of trans fats. A large portion of what
00:31:18.480 they consumed was safflower-based margarine, which at the time, again, was 25 to 40% trans fats.
00:31:27.240 It's really difficult to pick out, is this a polyunsaturated fat problem or is this specifically
00:31:35.260 a trans fat problem? And I would say, and I will argue that the human randomized control trials
00:31:43.780 that were not confounded by trans fats were actually probably better designed studies and better powered.
00:31:51.600 But I acknowledge that, okay, we're seeing some of these trials where higher cholesterol in the blood
00:31:59.320 is actually associated with lower mortality. One other thing it's important to point out is really
00:32:03.960 sick people, sometimes you can have what's called reverse causality, especially with cholesterol.
00:32:10.340 And let me explain. Once you get to a certain age, wasting diseases become a problem. High cholesterol
00:32:16.640 or low cholesterol, more specifically, low cholesterol can actually be an indicator of kind
00:32:21.600 of just overall poor health. That people with really low levels of cholesterol, they're more prone
00:32:27.680 to wasting. It may be more of a downstream effect than it is an upstream effect. And so this is where
00:32:34.180 it's really hard to pick out these sorts of things because it does get confounded by the reverse
00:32:40.340 causality, especially in people who are really sick. But even though the Sydney heart health study
00:32:45.160 was, as you said, a longer study, it was lower number of people. And even though they'd had a
00:32:51.880 cardiovascular event, the overall number of deaths was still pretty low, I believe. I think it was
00:32:56.540 somewhere around, I think it was under a hundred. Yeah. Total deaths were pretty low. 37 in the treatment
00:33:03.620 group, 28 in the control. Right. And that's a situation where when you're comparing 28 versus
00:33:09.260 37, just a few deaths, this is where you can have a sampling error, just a few deaths would have swung
00:33:15.360 the significance. And if you look at the confidence interval, the confidence interval nearly crossed
00:33:20.600 the one. And when a confidence interval crosses the one. Now, was that in the original analysis? I know
00:33:26.340 when the Ramsden re-analysis, it was 1.03 to 2.8. Was that what was originally published?
00:33:34.860 I actually don't recall if that was what was originally published.
00:33:36.860 Or maybe that was the original one. No, I'm sorry. That was the original published, I believe.
00:33:41.980 Yeah. That confidence interval is relatively wide considering the risk it's showing. And so,
00:33:49.260 because of course, the studies that support my contention, there's limitations on those as well.
00:33:54.580 But I think the most powerful thing, if I was going to pick it out, it's really the inclusion
00:33:59.060 of the trans fats, which is through no fault of the researchers of their own, because when these
00:34:03.400 studies were done, they just didn't know that trans fats had that effect.
00:34:07.840 Okay. So again, I'm playing the role of, I believe seed oils are bad. So the biggest contention we would
00:34:14.840 have if we go through the RCTs is because these RCTs were done at a time when trans fats were
00:34:23.780 the substitution fat du jour, I don't know how we're going to reconcile that. Basically,
00:34:29.320 it comes down to, do I believe that trans fats are less problematic than you believe? Because if
00:34:34.960 I believe that trans fats are actually not harmful, then that would take away your argument. You
00:34:41.200 wouldn't have an argument. Is there any other argument you've got besides trans fats on this?
00:34:46.060 I think the relatively short duration is another thing, because if we talk about some of the other
00:34:50.360 studies where it wasn't confounded by trans fats, some of those were longer, let me put it a different
00:34:54.780 way. Let's just say we take the trans fats out of it. Let's do that. And this was in the Ramsden
00:35:00.020 reanalysis as well. If we include all the human randomized control trials, looking at substituting
00:35:06.000 polyunsaturated fats for saturated fat, the overall effect is null. There was no effect one way or the
00:35:13.020 other. When you say that, you're referring to the largest Cochrane analyses. There are two, correct?
00:35:19.040 Yeah. Ramsden also did an analysis, I believe, where some of the trials that showed a benefit
00:35:24.260 to PUFA were confounded by the fact that there was omega-3s included in them. Now, I would argue that
00:35:28.520 if you look at the literature on omega-3s, it's actually not super strong that they decrease
00:35:33.540 hard cardiovascular disease endpoints. But nevertheless, it's a confounding variable.
00:35:37.760 So he took those out and then showed, okay, when we take out omega-3s, we see an increased risk.
00:35:44.240 But of course, that still includes the trans fats confounders. So if we just include both and lump
00:35:51.680 them all in together, the net overall effect is that one way or another, reducing saturated fat,
00:35:57.740 raising PUFA, it was equal risk. And so what I would say, if the statement is seed oils are uniquely
00:36:05.160 deleterious to human health, even if we take the trans fats out of it, and if you're going to allow
00:36:12.000 those to be included, you have to have, I call it, logical symmetry, which is if I'm going to allow
00:36:18.000 this confounding variable to support my point, I also have to allow your confounding variables to
00:36:22.420 support your point. Otherwise, we just got to find the ones that take both of them out. And so in that
00:36:27.160 case, the net effect is still no harm. What's the other confounding variable, the EPA and DHA?
00:36:33.380 Correct. If you want to start talking about some of these other studies, I will touch on the one other
00:36:37.540 study they cite is the Rose Corn Oil Trial, which I, quite frankly, I don't know what to make of it
00:36:42.320 because it was only like 70 people in the entire thing. Yeah, it was 26 people in a control group,
00:36:50.640 26 people on an olive oil group, and 28 people in a corn oil group. So again, this is a two-year
00:36:57.700 study. This was in people with significant cardiovascular disease. So the people in the
00:37:03.000 control group, business as usual, three of those people died. Five people died in the olive oil
00:37:10.020 group, but eight people died in the corn oil group. Sorry, that was total deaths for what it's
00:37:16.280 worth. Cardiac deaths, one in the control group, three in the olive oil group, six in the corn oil
00:37:23.080 group. Now again, the confidence intervals on this were very large because the sample size was very
00:37:29.320 small. This one is a bit challenging because the participants were given their oils. You could
00:37:35.080 think of this as kind of an early version of the PREDIMED study, where it was a free-living study,
00:37:41.360 but the participants were given olive oil when they were in the olive oil group. There were three
00:37:46.140 groups. There was low fat, and then there was high MUFA, high monounsaturated fat through olive oil,
00:37:52.100 and you were given a bottle of olive oil every week, or through nuts, and you were given the nuts
00:37:56.060 every week. So here, it was a free-living study, but you were given your corn oil, or you were given
00:38:00.600 your olive oil. Other than that, we don't have dietary recall. Now, the benefit, not confounded
00:38:05.820 by trans fats. There was no confounding with trans fats here, so that would be a positive. But I think
00:38:11.160 the first thing I would say is, I think you said this, the cardiovascular disease deaths were one,
00:38:16.440 three, and six. Yes. I don't know what to make of that. Those are such small numbers that you're so
00:38:22.540 prone to sampling errors, where if you'd had 10,000 participants, that's very likely going to get lost
00:38:29.200 in the wash. And let's just take the olive oil group. Even people who are anti-seed oil typically
00:38:35.720 acknowledge that olive oil is heart-healthy. Well, you had three times the deaths from cardiovascular
00:38:40.000 disease in the olive oil group compared to the control group. And so it doesn't fit with the
00:38:46.500 evidence we have. And it's so small. And like you said, the confidence intervals, I mean, if we want to
00:38:51.740 talk about a confidence interval being wide of 1.03 to 2.8 as being wide, the confidence interval in
00:38:58.240 this, I believe, was like 0.6 to 37. I mean- So not statistically significant either.
00:39:05.580 No, no. It was absolutely massive. And here's where my PhD advisor used to say,
00:39:11.040 if you torture the data enough, it will confess what you want it to show. And so if you just say,
00:39:15.700 well, there was six times the number of deaths in the polyunsaturated group, you're technically
00:39:20.560 correct. But you're leaving out a really big portion of the data. And again, when we plop all
00:39:25.800 these studies into the meta-analysis, don't take out any confounding variables. What do we see?
00:39:31.840 We see a null effect. Now, if we take out the trans fats, there was a meta-analysis, I think,
00:39:37.340 in 2017 where they put together all the trials. There were human randomized control trials looking at
00:39:43.440 substitution of polyunsaturated fats for saturated fats not confounded by trans fat. This was a very clear
00:39:49.940 benefit to substitution. I think it was around 20% reduced mortality risk.
00:39:57.180 No, it was even more. I mean, I have the luxury of cheating because I'm looking at the actual
00:40:01.740 figure. So the rose corn oil trial has the largest hazard ratio of any trial ever done.
00:40:08.440 Of this, I don't know, of any trial, of these trials, it was 4.64. What that means is there was
00:40:16.220 a 364% increase in risk if you took corn oil, but it did not reach anywhere near statistical
00:40:26.940 significance to your point because the hazard ratio confidence interval, the 95% confidence interval
00:40:32.400 was 0.58 to 37.15. So if we limit ourselves to this body of literature and the 1, 2, 3, 4,
00:40:44.600 5 studies, we do not achieve statistical significance, though we do have a trend towards risk.
00:40:52.700 That trend is 1.13, meaning a 13% relative risk increase.
00:40:58.640 If we include the trans fat, the trials.
00:41:00.240 Yes. So this is a bit of a messy analysis to your point because we're including the MCE,
00:41:05.900 we're including Sydney, but we're also including rose corn oil. We're just trying to get as many
00:41:10.860 bodies as possible through the engine of the meta-analysis and we don't reach significance.
00:41:16.340 In fact, the only study that reaches statistical significance is the Sydney heart study. That had
00:41:24.120 a 74% increase with a confidence interval of 1.04 to 2.91. So it got there, but I guess your argument
00:41:32.680 is going to be yes, but they were at 25 to 50% trans fats. So this is a tough one to score, Lane,
00:41:39.880 because on the one hand, it looks pretty bad for polyunsaturated fats here. Every time you eat
00:41:45.740 them, it just seems to move you in the wrong direction, except for the linoleic VA study.
00:41:50.560 Well, there's a few different human randomized control trials. So the VA study,
00:41:55.160 so there's several strengths to this study.
00:41:57.420 Tell us what the study was about.
00:41:58.700 So it was in veterans' homes. The food intake was controlled. They provided it to the participants.
00:42:04.260 And it was, I think, around 850 participants. And the average follow-up, I believe, was just under
00:42:09.680 nine years. So that's actually a pretty long study for this. Not confounded by trans fat,
00:42:15.740 and they did show, again, I don't have the raw numbers in front of me, but I think it was around
00:42:20.940 a 20 or 30% reduction in risk. It was, though it did not reach statistical significance. It didn't
00:42:26.980 have a wide confidence interval. It was actually quite narrow, but it crossed unity. So it had a
00:42:32.080 18% reduction in overall risk, but it was 0.56 to 1.21 was your confidence intervals. But this is one
00:42:41.580 that's on the other side of what you said a moment ago. They included omega-3s, if we believe that.
00:42:46.460 So the question is, did the omega-3s help, or was the study underpowered? Is that why it didn't
00:42:52.200 reach statistical significance? Or does it just not matter?
00:42:56.080 I mean, this is why we do meta-analyses. Because when it comes to single studies,
00:43:00.660 sometimes, especially when things are messy like this with hard endpoints, even if 800 people sounds
00:43:05.780 like a lot, when you're trying to get hard endpoints like mortality and cardiovascular disease events.
00:43:11.220 It's pretty small.
00:43:11.800 It's pretty small. There are some other trials out there. The Oslo Heart Health Study,
00:43:16.600 that was only 400 people, but that showed, I think, like a 47% risk reduction. Again,
00:43:22.220 confounded by omega-3s. Then there was probably one of the strongest studies, I think, is the Finnish
00:43:28.540 hospital study. And the reason is, not confounded by trans fats, not confounded by omega-3s. People
00:43:37.240 did each diet for six years, so it was a crossover design. So I guess it's important for me to cover
00:43:42.760 what a crossover design is briefly. So a crossover design is when you take people and you have them
00:43:48.100 do both treatments. Now, there are downsides. The downside is, okay, what about a crossover effect
00:43:55.960 where, okay, maybe you have, let's say, a cardiovascular event on one of the diets, but you did the other
00:44:02.820 diet before that. So is it from the diet you're on now, or is it from the previous diet? The way researchers
00:44:09.140 attempt to get around that is by essentially making the order in which they do both diets split, so that
00:44:17.160 there's 50% of people did one diet first, and then the next diet, and then they reversed it. Usually, you do that
00:44:23.620 by randomizing each individual person. Now, here's the weakness of the study. They didn't
00:44:29.000 randomize individually. They had two hospitals. One hospital started with one diet, one hospital
00:44:34.780 did the other diet, and then they switched them after six years.
00:44:37.900 Completely makes sense. Understandable.
00:44:40.040 Logistically, it makes sense.
00:44:41.080 Yeah.
00:44:41.340 Yeah. Otherwise, you're trying to like-
00:44:43.660 Figure out if Bob in bed A is on this diet versus Sally in bed B.
00:44:47.720 Exactly. I understand why they did it, for sure. I guess if you were going to try and make the argument
00:44:52.540 that this introduced a lot of bias, the argument you would make is that perhaps there was inherent
00:44:57.660 characteristics about one hospital versus the other that were more prone to people getting
00:45:02.480 cardiovascular disease. I would say that risk is probably pretty low, but it's an argument that
00:45:08.400 can be made. The benefits of this is it was 1,200 people, but since they crossed them over,
00:45:13.380 effectively, it was like 2,400 people. One of the benefits to a crossover experiment is
00:45:18.240 you can up your power.
00:45:20.560 I hope somebody listening is sharper than I am in my statistics because it's been so long,
00:45:25.500 and I used to know the answer to this. I think it's actually even more impressive than 1,200 to
00:45:31.620 2,400. I think it's even more, not to overuse the word power, but it's even more powerful
00:45:37.360 statistically when you do a crossover because every person gets to be their own control.
00:45:41.880 Exactly. That is probably the largest benefit, which is, as you said, it's the way you do the
00:45:48.220 t-test and the statistical comparisons. Each person is their own control because when you're
00:45:54.140 doing a parallel group design, which is where you just have one group on one diet, one group on the
00:45:59.300 other diet, you are assuming that the randomization process randomly distributes the baseline
00:46:05.060 characteristics that may be different between groups to where they're equally distributed amongst
00:46:09.060 the groups. But you don't know that for sure. But when you cross over, now you're guaranteed,
00:46:14.280 I don't want to say guaranteed, but you are very confident that inherent baseline characteristics are
00:46:19.880 now no longer a confounding variable. And it's likely that the people's overall lifestyles are
00:46:26.520 going to be similar throughout the course of the experiment. There's less risk of bias from
00:46:30.940 inherent lifestyle differences as well. Somebody having more stress versus less stress,
00:46:35.080 those sorts of things. And in this study, again, not confounded by trans fats,
00:46:40.300 not confounded by omega-3s, and pretty well-powered for a long duration, six years on each diet,
00:46:47.320 12 years overall. And they saw a pretty significant reduction in the risk of cardiovascular disease
00:46:53.420 events and mortality.
00:46:55.380 Yeah, 41% reduction in the treatment group that was, and just to give folks what the actual intervention was,
00:47:05.080 so the high saturated fat or control arm was 18% saturated fat, 4% polyunsaturated fat,
00:47:13.440 three to four, they gave some wiggle room. The treatment group was 14%, so they increased to 14%
00:47:19.320 polyunsaturated and cut saturated fat in half to 9%. These were kind of similar targets to the MCE study.
00:47:26.540 I want to say they measured linoleic acid in tissue too. I believe they did that.
00:47:31.080 I don't know.
00:47:31.820 If I'm wrong, I'll eat crow, but I think that they actually looked at like tissue and blood
00:47:36.220 biomarkers of linoleic acid and showed an increase in linoleic acid content to verify the
00:47:40.760 dietary treatment worked.
00:47:43.880 What would be your best explanation for this? Because again, the finished study,
00:47:47.960 I mean, 41% relative risk reduction in cardiovascular disease with that low saturated fat,
00:47:55.320 high polyunsaturated fat, and the confidence intervals are really tight.
00:47:59.580 I think, again, this is why this is a situation where, okay, I'm acknowledging
00:48:03.780 what seems to be a negative effect of polyunsaturated fats in some of these studies,
00:48:09.460 but I'm explaining why I think that the studies that show a reduction in risk are on balance better.
00:48:17.980 Again, not making a criticism of the researchers because, as we talked about, I think they did the
00:48:23.520 best they could at the time with the information they had. So this isn't an indictment on the
00:48:28.520 researchers whatsoever. But when you look at these studies that showed a reduction in risk,
00:48:33.480 they're longer, they're typically better controlled, and they don't have the inclusion
00:48:38.400 of trans fats. I think those things are the most powerful movers.
00:48:42.580 So we think that that is the best explanation for why the Finnish heart study came up with a
00:48:47.260 different answer.
00:48:48.040 Yes. There was a meta-analysis in 2017, and I can't remember the name of the lead author,
00:48:54.600 but they basically did a meta-analysis of the studies not confounded by trans fats. Now,
00:49:00.000 they included some of the ones that had fish oil in them, or omega-3s rather, but they showed overall,
00:49:05.420 again, I want to say it was around a 21, it was 29% reduction in risk. So again, if you look at
00:49:12.160 the Ramsden analysis, in their best case for polyunsaturated fats being bad, it's a smaller
00:49:18.280 increase in risk, and the confidence intervals are very wide.
00:49:21.780 So let me play devil's advocate for a moment. And again, this is sort of maybe a silly argument,
00:49:26.520 but what if this says more about saturated fats harm than polyunsaturated fats benefit?
00:49:34.540 Well, and this is a situation where when you're doing nutritional studies-
00:49:38.320 You have to substitute something.
00:49:39.560 Right, right, because-
00:49:40.760 If it's going to stay isocaloric.
00:49:42.000 One of the things when we were talking about doing this debate with the other individual,
00:49:45.660 I was very clear in saying, I'm not saying that there's no deleterious effect to seed oils
00:49:50.640 whatsoever, because added oils in the diet are a major source of calories, and excess calories
00:49:57.640 are not innocuous. So we have to compare apples to apples, which is when you are substituting in a
00:50:03.460 one-to-one ratio. What is more beneficial? The reality is, I think you could take any food or
00:50:10.780 any nutrient, and you can find both positive and negative pathways that it activates. The question
00:50:17.920 is not whether or not a nutrient or a particular food activates positive or negative pathways,
00:50:23.260 and I say that very broadly, because as you and I both know, there's not really such a thing as a
00:50:28.440 positive or negative pathway. But just in general, there could be positive and negative outcomes.
00:50:32.800 What matters is, on balance, what is the net effect? And I explain this, I'll use another
00:50:38.800 financial example. So we're talking about these pathways, we're talking about mechanisms,
00:50:44.440 which are important. If an outcome exists, there's a mechanism or mechanisms to explain it.
00:50:48.940 But those are like single stocks. An outcome, like a cardiovascular disease event, that is like
00:50:55.140 a mutual fund. And so what I mean by that is, I could take a mutual fund that's doing really well,
00:51:01.000 say, up 20% year over year. But I could find a few stocks in it. I'm like, oh, you don't want to
00:51:05.520 invest in this. Look at these, they're down like 50%. But what matters more, those individual stocks
00:51:10.200 that are down or the overall mutual fund is killing it? You care about what the overall mutual fund is
00:51:15.600 doing. And just an example of this, smoking decreases the risk of Parkinson's disease. This is
00:51:21.460 a very consistent effect in the research literature. But on balance, I don't think anybody's going to say
00:51:25.960 smoking is good for you. We should just point out to listeners, it appears to be the nicotine
00:51:29.900 that is causing that benefit. I don't want anybody with Parkinson's disease or at risk for Parkinson's
00:51:35.240 picking up cigarettes. If you're going to do anything, just choose some nicotine, choose
00:51:38.960 non-tobacco nicotine, please. But perhaps a better comparison would be, we know, I believe aspirin is
00:51:44.700 an anticoagulant overall, but it also activates some pro-coagulant pathways. But the overall effect is
00:51:50.780 anticoagulation. So if I just wanted to pick out and say, well, look, it activates these pathways,
00:51:56.540 not that it doesn't matter, but on balance, on balance, it is a net positive for anticoagulation.
00:52:03.780 And so when it comes to looking at polyunsaturated fats versus saturated fats, and we will get into
00:52:08.900 the mechanisms of these. Yes, there are mechanisms that exist that would suggest that polyunsaturated
00:52:15.080 fats can have a negative effect. But on balance, there are more mechanisms that exist
00:52:20.600 that show saturated fat to be a negative. To circle back to your original question,
00:52:26.180 is this a effect of polyunsaturated fats being beneficial or saturated fats being a negative?
00:52:32.420 I think it's almost impossible to disconnect those two questions because when it comes to
00:52:37.560 nutrition research, to do it accurately, you're looking at substitutions. So if you're going to
00:52:41.900 take saturated fat out, you've got to put something in. And so if we look at studies where you substitute
00:52:47.560 carbohydrate for saturated fat, not really much change. I would say that probably depends on the
00:52:53.460 type of carbohydrate very much. If you were doing like fiber dense sources of carbohydrate,
00:52:57.260 I'm pretty sure you'd see a reduction in risk. Monounsaturated fats, there appears to be a
00:53:02.260 reduction in risk of cardiovascular disease. It appears to be not quite as powerful, at least in
00:53:07.440 the cohort studies. But again, since we have to substitute something, let's make it very basic.
00:53:15.700 Even if there was no net, if polyunsaturated fats didn't do anything cardioprotective, it's still
00:53:22.240 cardioprotective in that when you put them in in place of saturated fat, you have improvements in
00:53:27.820 outcomes. I would argue that there are mechanisms in place that explain why polyunsaturated fats
00:53:32.640 are cardioprotective. My point I'm making is I think it's difficult to disconnect those two
00:53:37.800 questions. Do we know if the Cochran analyses on this question have blended and included the studies
00:53:46.060 across those that contain trans fats and those that don't? The one from 2017? Yeah. When they look at
00:53:52.000 all the PUFA versus SFA studies? No. So they specifically excluded ones that were
00:53:57.420 confounded by trans fats. Ramsden had one where it included basically all of them,
00:54:02.640 net effect being null, nothing. And when he pulled out the ones that were confounded by omega-3s,
00:54:08.920 they showed a negative effect of polyunsaturated fats. With trans fats still in? But with trans
00:54:13.760 fats still in. Okay. And Cochran had no trans fats. No trans fats. But did have omega-3s. But did
00:54:19.520 have omega-3s. And had a slight benefit to PUFA. Yeah. Well, pretty decent. I think, what did you say
00:54:24.560 it was? It was 20, I want to say it was like 23%, or no, 31%. Yeah, 29 or 31. Okay. Yeah. Yeah.
00:54:30.360 Somewhere around there. I apologize for not remembering the raw numbers. There's a lot
00:54:34.340 floating around in there. Has anybody done the analysis of excluding omega-3, excluding trans
00:54:40.440 fats? Well, I mean, you're basically down to- I know you're down to very few studies. I think
00:54:44.220 you're down to like two studies. I just want to ask a question. I apologize to interrupt.
00:54:49.540 That's good. When you say omega-3s, are you talking linoleic acid or are you talking EPA DHA?
00:54:57.640 I believe they're specifically talking about the EPA DHA. But I know like alpha lino-
00:55:02.960 Alpha linoleic acid. Yeah. Yeah. Alpha linoleic acid is omega-3 as well.
00:55:06.820 Alpha linoleic acid doesn't- Although no, that was part of it. That was part of it as well.
00:55:10.880 Because it doesn't convert very efficiently to EPA and DHA. So does that mean that these
00:55:16.400 studies that contain omega-3s are going out of their way to supplement with EPA and DHA,
00:55:22.300 which of course you can really only get in high quantities from marine sources?
00:55:25.260 It wasn't clear in the research literature I read. It was just basically like, yeah,
00:55:30.520 there was some omega-3s in the diet. There's basically, I think, two studies that were not
00:55:35.740 confounded by trans fats, not confounded by omega-3s. And that was the Finnish study that
00:55:39.900 we talked about. And then STARS, which STARS was not looking at hard cardiovascular disease endpoints.
00:55:46.860 This was looking at plaque progression. So I believe this was a one-year study and they looked
00:55:52.000 at either people doing low saturated fat, higher polyunsaturated fat versus higher saturated
00:55:56.660 fat, lower polyunsaturated fat. And they looked at the progression of plaque. So not hard outcome,
00:56:04.340 but I would say that the strength of this is since you are looking at the progression of what we know
00:56:10.880 causes these myocardial events, even if you don't have a myocardial event, you can get a really good
00:56:17.680 idea of what's going on. And so, for example, and I'm just going to make a hypothetical here,
00:56:22.940 you could have somebody in one of these other studies where they got right up to the point
00:56:27.020 where they got like a 99% blockage, but no myocardial event in the time where they were
00:56:31.620 measuring it. And they just came up as that's a risk reduction. But in reality-
00:56:36.400 They had disease progression.
00:56:37.520 Right. So the benefit of this is you still get a harder endpoint than just biomarkers,
00:56:42.860 but you can get a little bit more granular than just looking at, I guess, the way to describe
00:56:47.380 mortality and cardiovascular disease events as big blunt instruments.
00:56:51.820 So let's talk a little bit more about these mechanistic things now, because again,
00:56:55.480 most of these trials were done with a brute force tool of like the hardest outcome is all-cause
00:57:02.200 mortality. But again, that's a high bar. When you do clinical trials, you trade off between outcome
00:57:08.200 and barrier to outcome, for lack of a better term, right? So if you want to use all-cause mortality,
00:57:13.840 that is the ultimate measuring stick, but it's a high bar to clear. And then you can go disease-specific
00:57:19.040 mortality. Okay, we're now going to look at coronary death. Then you can go one step lower,
00:57:23.240 and an example would be MACE, major adverse cardiac events, where we're going to use heart attack
00:57:27.700 and stroke and cardiac death. And then you can go one step below that and say, well, we're just going
00:57:32.300 to look at a change in cholesterol, or we're going to look at a change in LDL cholesterol.
00:57:35.780 And you get more and more insight into disease process, or I guess below MACE,
00:57:40.400 you would go disease progression would actually be your next thing.
00:57:43.060 Right. That would be what stars did.
00:57:43.560 Yeah, yeah. Let's go from the macro to the micro.
00:57:46.820 Before we do that, you may disagree, but I think now would be a good time to talk about
00:57:50.600 the Mendelian randomization studies, unless you want to do progression first, or unless you want
00:57:55.320 to do the mechanism first.
00:57:56.840 Okay. Do you want to talk about Mendelian randomization through the lens of LDL?
00:58:00.460 Well, yes. Okay. So first off, I think it's important to point out why I'm bringing this
00:58:06.040 up now. Because when it comes to these studies, I think that these are the most powerful. Because
00:58:11.200 as you mentioned, mortality is a difficult outcome to get. It's a high bar to clear.
00:58:16.200 The benefit to Mendelian randomization is that essentially you have a lifelong randomized
00:58:21.000 control trial. Now, Mendelian randomization takes advantage of the fact that at birth, genetic
00:58:27.000 variants are randomly assigned. So in a research study, if you and I are in a research study,
00:58:31.960 Peter, the researchers are just going to, through whatever randomization process they
00:58:35.580 have, okay, Peter, you're doing this. Lane, you're doing this. Completely random. Mother
00:58:40.080 nature actually does that by design, which we now know identified, I think around a dozen
00:58:45.860 variants that will essentially change your LDL cholesterol levels. They're variants that deal
00:58:53.220 with LDL clearance, LDL production, how much cholesterol you absorb. There's all different
00:58:58.440 kinds of variants. Now, the benefit to this is you can look at someone's lifelong LDL cholesterol
00:59:04.680 exposure and attempt to see what is the risk of mortality and cardiovascular disease. That
00:59:12.080 is very powerful. And these are studies where some of these have hundreds of thousands of people
00:59:16.800 in them. And again, the randomization of this process by nature is so important because now we
00:59:25.480 can, if we see differences between groups, we can assume it's due to that assignment of that genetic
00:59:32.160 variant versus some kind of confounding variable. Now, there's a caveat here, which is for a Mendelian
00:59:40.140 randomization to be useful, a couple of things have to be true. What you said has to be true.
00:59:44.840 There has to be genetic assignment to the variable of interest. That's true for many things. It's true
00:59:51.360 for height. It's true for body composition. It's true for many psychiatric disorders. I mean,
00:59:57.420 there's lots of things for which genetics play a significant role. And LDL cholesterol turns out to be
01:00:04.060 one of them. But this is the other important thing that people often forget when talking about MR,
01:00:08.860 which is that those same genes cannot have a direct impact on another variable that affects
01:00:17.820 the outcome of interest. Because if they do, your randomization just got wonky.
01:00:23.520 For sure. And that's why they do tests for pleiotropy, which we talk about. And when I talk
01:00:28.880 about the results, I'm going to explain why it's very unlikely that these differences were due to
01:00:32.880 pleiotropy. But it does require us to make one assumption. And this may seem ticky-tacky,
01:00:38.220 but I'm trying to be logically consistent here. Which is, this is not a lifelong test of saturated
01:00:44.260 fat versus polyunsaturated fat. This is a lifelong test of what we expect to happen to LDL cholesterol
01:00:50.280 by substituting polyunsaturated fats for saturated fats.
01:00:53.720 Stated another way, this is a test of LDL causality.
01:00:58.060 Correct.
01:00:58.980 It's a leap to then make the statement about what does nutrition do to this. I'm going to give
01:01:04.520 you another example of this that is off the beaten path, but related to LDL, but unrelated to our
01:01:09.480 topic. And I believe I included this in my book, although it may have got left on the editing floor.
01:01:15.400 I know I wrote about it. I can't remember if it made the final cut. And it came down to the question
01:01:19.480 of, so this is me taking off my debate hat and just doing an aside on MR because it's interesting.
01:01:25.280 A handful of studies showed that people with lower cholesterol were more prone to cancer.
01:01:30.880 And so the concern became, well, gosh, we shouldn't be lowering people's cholesterol
01:01:34.420 in an effort to prevent heart disease if it increases the risk of cancer. And of course,
01:01:39.540 on average, that didn't seem to be the case, but there was always one study that might've
01:01:43.160 suggested that. And you never knew if there was a confounder because cancer, you weren't
01:01:46.620 randomizing to find that. So this is where MR became potentially valuable, provided you believe
01:01:52.040 that the genes that regulate cholesterol, synthesis, absorption, and LDL receptor expression don't
01:01:59.260 also regulate a cancer process. And if you believe that, then the Mendelian randomization was quite
01:02:05.380 clear that there was no relationship, neither good nor bad, between LDL, cholesterol, and cancer.
01:02:13.600 So that meant that LDL had no causal role one way or the other on cancer, whereas, as you'll probably
01:02:20.280 talk about it as a relationship towards ASCVD.
01:02:23.420 So that's a great explanation. And I think it took me a while to wrap my head around Mendelian
01:02:28.380 randomization when I first started reading about it. But these really were the studies that made me
01:02:32.320 change my mind on LDL. I want to point out the strengths to this. Lifelong exposure, which based
01:02:38.720 on the lipid hypothesis, we would expect to see a linear effect of lifelong exposure to LDL on the risk
01:02:45.480 of cardiovascular disease and mortality. And you can get a large number of subjects for their lifetime.
01:02:52.940 And it's randomized. So it's not a cohort study. Those are the benefits. The one downside is, again,
01:02:58.420 we're having to make a leap of, okay, we're not directly measuring people eating saturated fat versus
01:03:02.920 polyunsaturated fat. But I would say that this leap is pretty small because it is very well established
01:03:08.880 that increasing saturated fat intake increases LDL cholesterol and increasing PUFAs decrease LDL
01:03:16.140 cholesterol. And raising PUFAs and lowering saturated fat significantly decrease LDL cholesterol. I think
01:03:22.460 in most studies, you get like around a 15% change in LDL cholesterol from substituting in polyunsaturated
01:03:28.860 fats for saturated fat. Now, I will tell you, there's a paper from, I think it's Forenz in 2012.
01:03:35.520 It was the first big MR study with cholesterol. And if you look at the figure where they take
01:03:42.140 all the genetic variants and you look at how the line goes almost straight through it. I mean,
01:03:48.860 we're talking about an R of probably above 0.9, which in studies like this, that is an incredible
01:03:55.420 association for every one millimole reduction in LDL. Which is about 37 milligrams per deciliter.
01:04:02.940 It's 39.4 milligrams per deciliter. Yeah. There was a 50 to 55% risk reduction in cardiovascular
01:04:09.880 disease. Again, the pleiotropy argument is pretty much null and void because it didn't matter what
01:04:15.600 kind of variant it was. If it increased LDL clearance, if it decreased production, no matter
01:04:22.340 how it affected the metabolism of LDL cholesterol, it had the same dose effect. The only exception to that
01:04:30.520 was some of the CETP variants, which when it came to drug trials as well, CETP variants,
01:04:36.540 basically, I believe they raise HDL and they lower LDL. But, and here's the big point,
01:04:41.460 the lowering of LDL with those variants and those drugs, it lowers the cholesterol mass,
01:04:47.860 but there's a discordant lowering of ApoB or LDL particle number. So every single LDL particle
01:04:55.520 has an ApoB protein on it. And when we get into the mechanisms, this is going to be very central to
01:05:00.540 the lipid hypothesis. If you lower cholesterol mass, but your ApoB doesn't drop that much,
01:05:06.020 you basically have just made each particle smaller. And what we see is in that particular
01:05:12.060 subset of variants, there is a small risk reduction, but it's basically explained by the
01:05:17.460 small decrease in ApoB. You don't get the predicted risk reduction that you would get
01:05:22.460 with reducing LDL cholesterol. But amongst the variants that decrease LDL and correspondingly
01:05:28.960 decrease ApoB, it is a very, very consistent effect. Again, regardless of the genetic variant,
01:05:36.080 it has the same risk reduction. And then when we look at the statin trials, regardless of the way
01:05:41.400 that LDL cholesterol gets lowered, and there's different statins that work different ways,
01:05:45.940 it is the same dose response, which is about 22%.
01:05:48.460 Yeah. So I was going to ask you, why do you think that when we look at the totality of the
01:05:54.920 Mendelian randomization, and Tom Dayspring has a figure that lays every single MR study,
01:06:02.940 every single RCT study, and every single observational epidemiology study on the same
01:06:09.680 graph with three lines, basically the linear regression through each. And what do you think
01:06:16.000 is the best explanation for the following observation, which is when you do all of the MR
01:06:19.940 studies, and just again, so people, especially because most people are listening to us, not
01:06:24.220 watching us, so I don't want to use my hands too much, but on the x-axis, you have LDL concentration,
01:06:29.840 and on the y-axis, you have mortality or cardiovascular mortality. And as you pointed out,
01:06:35.400 these lines are just going straight down, meaning as LDL cholesterol is going down, either genetically
01:06:42.500 or through drugs, cardiovascular mortality is going down. But why is it that in the MR study,
01:06:49.680 which in theory would be the most pure study, every millimole or every roughly 40 milligrams
01:06:55.200 per deciliter reduction in LDL cholesterol is giving you 50 to 55% reduction. But when you do the same
01:07:02.160 thing with a statin, you still get a benefit, and that benefit appears non-ending, but it's only 22%.
01:07:08.500 Doesn't that tell us that statins are bad? Well, again, as you mentioned, there's still
01:07:12.820 a risk reduction. Yeah. Let me state it another way. Does that suggest that while statins are net
01:07:18.480 positive, they're doing something bad? So this is because think about when people are getting on
01:07:25.360 statins. So I say this as somebody, my bias should be that I hope that LDL cholesterol is not bad because
01:07:31.800 my whole mother's side of the family runs high LDL, even with low saturated fat diet, even with high
01:07:37.820 dietary fiber intake, I run about 150. I started taking a statin when I was 40 years old. But my
01:07:44.020 endothelium, my blood vessels have already had 40 years of LDL exposure at that level. And so even if
01:07:52.960 I get on a statin at age 40, every single day to the day I die, there is still some LDL cholesterol
01:07:59.780 that has penetrated that endothelium and has contributed to some degree of atherosclerosis.
01:08:06.980 I mean, I had a coronary calcium score done. It was pretty low. Overall, my net risk was very low for
01:08:12.240 my age because I have good insulin sensitivity, all those sorts of things. Important to point out as
01:08:16.260 well, when we're talking about LDL, we're not saying everything else doesn't matter. This is an
01:08:20.260 independent risk factor is what I'm saying. Insulin sensitivity, metabolic health, all those things
01:08:24.600 still matter. These are not mutually exclusive. But when you have a genetic variant that lowers LDL
01:08:31.080 from the day you are born, your entire circulatory system is exposed to less LDL cholesterol. And when
01:08:38.400 it comes to how much gets into the intima, it is concentration dependent. And it's basically dependent
01:08:46.200 on the number of particles in your bloodstream with ApoB that are under 70 nanometers. Because
01:08:54.900 any lipoprotein under 70 nanometers in diameter with an ApoB can penetrate the endothelium and get
01:09:02.500 retained there. So when it comes to these Mendelian studies, the reason you see such a powerful effect,
01:09:08.260 it's just a time effect. Because most people, when are they getting, I don't know what the average age
01:09:11.600 is somebody's prescribed a statin, but I'm imagining it's probably around my age. Yeah.
01:09:14.800 Yeah. So you're really just looking at the difference in like that investment analogy we
01:09:20.000 used earlier, 40 years, you'll see a big difference. But if you start investing from the day you were
01:09:24.620 born in 70 years, you're going to see a massive difference due to compounding interest. And while
01:09:30.680 it may be kind of a rudimentary comparison, these problems compound over time. And so what you're doing
01:09:36.520 with somebody who has high LDL, put them on a statin, you're obviously like pumping the brakes,
01:09:42.420 but that truck still started rolling down the hill. Whereas with people who have lifelong low LDL,
01:09:47.920 it never really got started.
01:09:49.200 Yeah.
01:09:49.960 I want to point out one more thing. Important to point out, there was a regression. They looked at each
01:09:54.020 one millimole reduction. So regardless of the variant, same reduction. And in the drug trials,
01:10:01.760 the statin trials, regardless of how the statins worked. Also with surgeries, like I think it was
01:10:09.200 a little bypass or things that reduce LDL through absorption.
01:10:13.600 No, I think different drugs that are independent of the mechanism by which LDL is lowered.
01:10:19.140 Yeah.
01:10:19.540 You'll see the same benefit.
01:10:20.800 And then also with dietary reduction of it in terms of the risk when they look at some of these cohort
01:10:25.900 studies. If you want to argue it's pleiotropy or you want to argue it's possibly something
01:10:31.460 else, it's a really hard argument to make when it is a very consistent effect and the dose is also
01:10:39.080 very consistent. When we talk about converging lines of evidence.
01:10:43.240 There's an argument to be made, which is not necessarily the argument we're having today.
01:10:46.460 I won't even attempt to steel man it. I'll just state it. The argument is that if you look at all
01:10:51.220 the literature of statins and you see reduction in mortality, that doesn't mean that it's because
01:10:57.380 it's lowering LDL. It could be because it's doing something else. It's lowering inflammation
01:11:01.700 or it's doing something else. And you're arguing that that's a tough argument to make in light of
01:11:07.460 all of the MR coupled with all the clinical trial data.
01:11:10.980 If that was the case, you would see a difference in the dose response. You would see inconsistencies
01:11:17.000 in the trials with similar designs. I'll give a comparison that's kind of out of left field,
01:11:21.880 but maybe it'll make the point. And that is, for example, I don't believe that unprocessed red meat
01:11:28.240 specifically is inherently carcinogenic. And the reason is, even though you see it come up as
01:11:36.140 carcinogenic in some of these cohort studies, the effect isn't always consistent. And when they
01:11:41.700 control for overall diet quality, where people are eating enough fruits and vegetables, because again,
01:11:45.900 if people eat more of one thing, they tend to eat less of another. When you control for some of the
01:11:50.160 overall diet quality variables, you don't really see a consistent associated of red meat with cancer.
01:11:56.180 Now, I could be wrong, but I'm just not convinced by it. But when it comes to dietary fiber's effect
01:12:01.960 on cardiovascular disease and cancer, there's a dose response and it is very consistent in the
01:12:08.700 research literature. In fact, I'm not really aware of hardly any study looking at dietary fiber
01:12:14.860 and reducing the risk of cardiovascular disease, cancer, and mortality that doesn't show a benefit.
01:12:20.160 If there's a forest plot of all the studies out there, everything is going to be the protection
01:12:24.880 side. When you have that consistency, even though you could argue, well, it could be other things,
01:12:30.140 it could be other things. I guess if you want to make the whataboutism argument, it's hard for us
01:12:35.380 to ever actually say something causes something else. I mean, maybe it's not the smoking that causes
01:12:41.740 lung cancer because we can't really do randomized control trials on smoking because it wouldn't be
01:12:48.680 ethical, but we feel very strongly because of the dose effect and because of the consistency of the
01:12:53.280 results. So I get that argument that can be made, but I guess I would say, well, then what do you
01:13:01.840 think it's doing? What would explain this very consistent effect? It typically just ends up being
01:13:07.120 an argument of, well, you don't know for sure. And it reminds me of in graduate school, I was giving a
01:13:12.480 talk on leucine content of dietary protein sources, and we did a dose response experiment
01:13:17.800 with different dietary protein sources that varied in the leucine content, and pretty much showed almost
01:13:23.440 a perfect association between the amount of leucine in those protein sources, the ability of those
01:13:29.100 protein sources to increase plasma leucine, and the effect on protein synthesis. And I had people
01:13:34.140 that were other scientists in the audience say, well, but you can't say that. These other protein
01:13:37.880 sources, they have different other amino acids in them. It's not just leucine. There's other things
01:13:41.860 that are changing. And I said, okay, do you have anything else that would explain this? It was kind
01:13:47.840 of like they didn't really have much to say. And so yes, I grant that it's possible. It's just highly
01:13:53.700 improbable based on the data. Okay. So what about the idea though, that if you're eating a diet that's
01:14:00.260 high in polyunsaturated fats or seed oils to be specific, we acknowledge now you're getting a lot of
01:14:05.940 linoleic acid. Well, you now have LDL particles. Maybe you have not only fewer of them, but they
01:14:14.640 have more linoleic acid in them. And linoleic acid can easily be converted to arachidonic acid,
01:14:22.480 which is inflammatory. And we know that the single most important part of atherosclerosis is indeed the
01:14:29.320 oxidative inflammatory process. In fact, people don't die because their coronary arteries just
01:14:35.840 slowly get occluded. They die because the body in an effort to repair and respond to the oxidative
01:14:44.680 damage in the artery walls creates an immune response. So inflammation here is the game.
01:14:52.240 So are you not concerned with the fact that a diet that is high in linoleic acid, which is the
01:14:58.340 precursor to arachidonic acid, is going to lead to more inflammation, more oxidative LDL, and therefore
01:15:07.500 ultimately more atherosclerosis, even if you see lower LDL cholesterol? So this is going to be the
01:15:14.420 really fun part of this talk because I learned so much about this through researching this stuff.
01:15:20.600 Let's just take the broad 10,000-foot view first, and then we'll zoom in on the mechanisms and talk
01:15:27.160 about the lipid hypothesis because it's important to understand what it is and how this disease
01:15:32.900 progresses so that then we can unpack all these side quests. And I'll take what you said a step
01:15:38.780 further. Precursor to arachidonic acid, which is a precursor to prostaglandin production, which are
01:15:43.760 inflammatory. Also, and you did briefly mention this, polyunsaturated fats, much more prone to
01:15:49.300 oxidation than saturated fat. And we do know oxidized LDL is more atherogenic on a per-particle
01:15:56.100 basis. And people who have MIs, people who have cardiovascular disease, they have higher levels of
01:16:02.900 oxidative LDL. So really, when we nail it down, I believe that's one of their big core arguments is
01:16:09.100 when you substitute polyunsaturated fats for saturated fats, you are creating an unstable
01:16:15.480 lipoprotein, more prone to oxidation, and that is what is going to cause this disease to really
01:16:21.920 progress. Let's unpack this a little bit. From a 10,000-foot view, if that were true, what we would
01:16:28.460 expect to see is people who eat more linoleic acid have higher rates of heart disease. And what we see
01:16:35.460 is the opposite. I think there was a study that came out, a cohort study looking at like,
01:16:39.800 I think it was over a million people from various different countries showing that people who had
01:16:46.180 higher levels of linoleic acid intake had lower levels of cardiovascular disease.
01:16:52.240 What was that a substitute for? This was a free living study, right?
01:16:55.340 This cohort. So they're just looking at how much do linoleic acid do people eat?
01:16:59.660 And what was the primary source of the linoleic acid?
01:17:02.020 I'm not sure. I think they just looked at overall dietary linoleic acid
01:17:05.100 If I really dug back into the paper, they might list some of the primary sources.
01:17:09.500 But of course, these people are probably substituting linoleic acid because they're
01:17:14.320 healthier people to begin with.
01:17:16.060 Healthy user bias. What I would say when it comes to healthy user bias, what you typically see is like
01:17:22.800 no effect of something that should be bad or it'll be inconsistent in the research literature.
01:17:28.620 But it's hard to argue converging lines of evidence. If your position is that CEDOLs are uniquely
01:17:34.560 deleterious, it's hard to argue converging lines of evidence when one of the major things you really
01:17:40.300 should see is if people eat more linoleic acid, the effect should be so powerful. If they're the
01:17:44.800 primary driver of cardiovascular disease, which is what some of these people claim, that effect should
01:17:48.800 be powerful enough that even if they were doing other healthy behaviors, that you should still see
01:17:55.700 something and certainly not a protective effect. To take it one step further, because dietary recall studies
01:18:01.200 are problematic. Anybody who's ever done some of these knows. I mean, I don't even remember what I
01:18:05.820 ate yesterday. But one of the great things about the fatty acids you eat, the essential fatty acids
01:18:11.200 you eat, is if you eat more of them, it shows in your tissues. If you take an adipose tissue sample,
01:18:16.600 if you take a blood sample, you will see more of that essential fatty acid incorporated into your
01:18:23.360 lipid, your phospholipid bilayer of your cells.
01:18:26.500 And indeed, in studies where they look at tissue amounts of linoleic acid, they see the same thing,
01:18:33.600 a reduction in risk of cardiovascular disease. So this is from a 10,000-foot view. To me,
01:18:38.800 that's a pretty damning thing right off the bat. And what I would say is, if you're going to argue
01:18:43.320 that polyunsaturated fats are bad for you, you're going to argue that saturated fat is really bad for
01:18:47.840 you. Because if, again, I think that's where logical consistency is important. If the data existed
01:18:54.180 showing people who ate more saturated fat had lower rates of cardiovascular disease,
01:18:59.360 if you even thought about talking about saturated fat being bad, the people in the anti-seed oil camp
01:19:05.220 or carnivore camp would lose their minds. And so it's kind of like this picking and choosing of
01:19:10.160 what data I want to talk about that fits. So we don't see that. We also don't see that when people
01:19:17.040 eat more linoleic acid, they don't produce more economic acid. That conversion apparently is already
01:19:22.720 kind of at saturation. Just eating more linoleic acid doesn't have a feed-forward effect.
01:19:28.720 You're not actually getting more arachidonic acid production. So I think the prostaglandin pathway
01:19:33.980 is not something we really need to be too concerned with. Because again, we'd expect to see increasing
01:19:39.240 amounts of arachidonic acid. Now this is where I think the oxidized LDL is the argument that I
01:19:45.220 struggled with the most before I really dug into this. So I'm going to talk about the lipid hypothesis,
01:19:49.480 and then I'm going to also talk about why it's so important to understand where LDL gets oxidized.
01:19:55.480 So the lipid hypothesis basically states that really any non-HDL cholesterol that is under 70
01:20:02.800 nanometers in diameter, which VLDLs can fall into that, LDL obviously falls into that, IDLs can fall
01:20:09.640 into that, depending on the IDL. But basically any lipoprotein that contains an ApoB molecule,
01:20:17.440 or an ApoB protein, that the lipoprotein is under 70 nanometers in diameter, can penetrate the
01:20:23.120 endothelium. Now just penetrating the endothelium and getting into the intima, and this is concentration
01:20:27.840 dependent, and this has been very well established in the mechanistic literature, but just penetrating
01:20:32.580 the endothelium is not enough to cause progression of cardiovascular disease because those molecules
01:20:39.360 can come back out into the bloodstream. What can happen is that ApoB molecule, or that ApoB
01:20:45.820 protein, can be enzymatically modified into a proteoglycan. Basically enzymes inside the intima
01:20:55.580 can act on that ApoB. That enzymatic modification causes that LDL or VLDL or whatever particle it is
01:21:04.240 to be retained inside the intima. Once retained, that causes an oxidation. Oxidation can increase
01:21:11.760 on those lipoproteins. That can attract macrophages, as you pointed out, the immune response. Those
01:21:19.860 macrophages begin to engulf some of these. These LDL particles can start to clump together, or VLDL
01:21:27.080 particles or whatever particle. They start to clump together in a process called aggregation.
01:21:31.840 Macrophages infiltrate inflammation, trying to, again, repair this. But those macrophages,
01:21:38.580 then engulfing them, this produces foam cells. And over time, you also get more, I think the smooth
01:21:46.680 muscle starts to thicken as well. And this is eventually what's leading to kind of this closing
01:21:51.780 of the blood vessel. Now, oxidation is part of this process. One of the core components that you
01:21:58.700 mentioned of this anti-seed oil hypothesis is that, okay, if you have lipoproteins that have more
01:22:03.440 polyunsaturated fats, they are more prone to oxidation. That is true. But we need to understand
01:22:08.640 where oxidation is occurring. I think anti-seed oil people would have you believe that the
01:22:13.760 oxidation occurs in the plasma, and that those oxidized LDLs in the plasma, those penetrate the
01:22:19.720 endothelium, and that causes the progression of cardiovascular disease. Less than 1% of LDL
01:22:25.380 is oxidized in the plasma. Because LDL is mostly cleared pretty quickly from the plasma. It's like
01:22:32.300 an hour or two. It's on the time course of hours. Once ApoB is enzymatically modified, that LDL,
01:22:38.580 that can be retained for weeks. And in your plasma, you have antioxidants, vitamin E, vitamin C,
01:22:46.400 beta carotene. Those stabilize those polyunsaturated fats, and you don't really have that much
01:22:52.640 oxidation occurring in the plasma. But in the microenvironment of once it penetrates the
01:22:58.440 endothelium, gets inside the intima, in that microenvironment, it's thought that those antioxidants
01:23:04.620 are not as available. And so the oxidation can begin to occur there.
01:23:10.380 So what's the proof? So you're saying that because plasma ox LDL concentration is such a small fraction
01:23:18.520 of total LDL concentration, say 1%, that means that we're not getting a lot. But it could be a lot
01:23:25.080 if that 1% disproportionately aggregates inside the subendothelial space. I mean, you don't need a lot
01:23:31.600 of LDL particles to cross the endothelial barrier, right?
01:23:35.100 I'm glad you brought up aggregation because that's important here. So remember when I said there can be
01:23:39.740 positive and negative aspects that you activate for any nutrient you're talking about. So aggregation,
01:23:46.800 once you have LDL inside the intima and you have this oxidation occurring, you have these things
01:23:52.500 occurring, aggregation is how these cells clump together. Lipoproteins that are enriched with
01:23:58.320 polyunsaturated fats per particle, they are more prone to oxidation. Yes, inside the intima. But keep
01:24:05.520 in mind, what gets into the intima is concentration dependent. Polyunsaturated fats overall lower the
01:24:11.680 amount of LDL getting into the intima. So you have less getting in, less being accessible for
01:24:18.800 oxidation since it occurs there mostly, not the plasma. But a bigger point is there's other aspects
01:24:25.480 of these lipoproteins that make aggregation happen. So when we talked about polyunsaturated fats
01:24:33.400 increase membrane fluidity, one, that actually helps with LDL receptor recognition. It helps LDL get
01:24:39.560 cleared so you have less in the bloodstream. But two, the ApoB molecule itself is less prone to
01:24:46.940 enzymatic modification on LDLs that are enriched with polyunsaturated fats compared to saturated fat.
01:24:53.320 Further, LDL molecules that are enriched with saturated fat, their membranes are stiffer and more
01:25:00.300 rigid because of the packing that we talked about. Whereas those enriched with polyunsaturated fats
01:25:05.940 are less rigid, they're more fluid. And that has a big impact on aggregation. There's an enzyme called
01:25:14.060 sphingomyelinase, which when it acts on a saturated fat enriched LDL molecule inside the intima,
01:25:21.580 it rapidly produces ceramides. And those ceramides actually, for lack of a better term, can collapse
01:25:28.420 these particles and cause them to clump together much more readily. So all that to say, oxidation is
01:25:36.220 part of the process of aggregation, but how much those aggregate is a more important factor than
01:25:42.680 oxidation of PUFAs. Because the oxidation is bad because it increases the aggregation of these
01:25:49.560 molecules. So the overall effect is, okay, polyunsaturated fats decrease the number of particles
01:25:57.040 that are getting into the intima. They also overall decrease them being retained there,
01:26:03.260 the ApoB is less prone to modification, and they are less prone to aggregation if they are retained
01:26:08.680 there compared to lipoproteins that are enriched with saturated fat. So think of it this way. I really
01:26:15.220 spent a lot of time trying to come up with an analogy for this because I realized a lot of people who are
01:26:20.120 listening to this, their heads are probably spinning because mine was spinning when I was reading about
01:26:23.380 this at first. Think about the LDL cholesterol in your bloodstream, or let's just say ApoB containing
01:26:28.300 particles in your bloodstream, being a bonfire. And there's a whole forest around it. Now the forest
01:26:33.200 around it is your blood vessels. And if you start a forest fire, that's cardiovascular disease.
01:26:39.080 Now, bonfires, they give off sparks. Let's say each spark is an LDL particle. You don't want the forest
01:26:45.720 to catch on fire. If you have polyunsaturated fat enriched fatty acids, maybe each individual
01:26:52.700 particle is a little bit more flammable, right? Or a little bit more prone to oxidation. But when you
01:26:59.780 eat high polyunsaturated fats versus saturated fat, your bonfire shrinks quite a bit. The amount of LDL
01:27:06.580 in your bloodstream shrinks quite a bit. You give off way less sparks, way less sparks hit the forest. And oh,
01:27:12.420 by the way, if I was being actually accurate, some of those sparks are much more likely to bounce back
01:27:17.160 into the fire compared to staying in the forest where they can start a fire. Also, these particles
01:27:23.280 tend to, even if they get into the forest, these sparks, they tend to not clump up and be prone to
01:27:30.700 causing a forest fire. They tend to scatter. That's polyunsaturated fat enriched lipoproteins. So even
01:27:37.260 though on an individual level, the sparks may be a little bit more flammable, the bonfire for saturated
01:27:44.240 fat is way bigger. It casts off way more sparks. And those sparks are more likely to clump together
01:27:51.760 and start a fire compared to the fire from polyunsaturated fats. That's about as good of
01:27:57.240 an analogy as I could come up with.
01:27:59.060 And you're rejecting my idea that even though only a small fraction of LDLs are being oxidized in the
01:28:08.560 periphery, that those ones don't disproportionately concentrate in their ability to either make their
01:28:15.940 way into the endothelial or subendothelial space and get retained. I feel like we're potentially
01:28:21.040 overlooking that as a potential driver, right? Because LDLs can traffic in and out of the subendothelial
01:28:25.760 space. So the question then becomes, what are the factors that would increase retention,
01:28:32.300 adhesion, oxidation, and then the cascading effects? And do we not believe that an oxidized LDL versus a
01:28:41.800 non-oxidized LDL would be more atherogenic?
01:28:45.680 On a per-particle basis, yes. An oxidized LDL is more atherogenic.
01:28:50.900 In the periphery.
01:28:51.720 So you're saying like in the bloodstream.
01:28:53.380 Yes. I know it is inside, but I want to make sure we would agree that potentially it would
01:28:58.340 also be more atherogenic outside because it has a greater probability of becoming retained
01:29:04.080 and remaining oxidized and inciting the inflammatory response.
01:29:08.500 It's just such a small amount that gets oxidized.
01:29:11.400 Has anyone looked at a study where, you know, asked the question if you are on a high polyunsaturated
01:29:18.180 or seed oil diet versus a high saturated fat diet and you normalize for total LDL, which
01:29:23.540 obviously will be quite different, do you have an equal percentage of oxidized LDL in
01:29:28.800 the periphery?
01:29:29.640 Say it again one more time.
01:29:30.960 Let's just assume you put somebody on a high saturated fat diet, somebody on a high seed
01:29:34.660 oil diet. And let's assume that the PUFA person, the seed oil person's got an LDL cholesterol
01:29:39.300 of a hundred milligrams per deciliter and the high saturated fat diet person is going
01:29:44.180 to be at 200 milligrams per deciliter. And let's just assume that that's concordant with
01:29:47.540 APO-B. So same number of particles, 2X the particles, 2X the concentration, I mean.
01:29:52.240 Do we expect there to be the same ratio or delta or fraction that's oxidized? Or do we think
01:30:00.120 that the person on the high seed oil is going to have disproportionately more ox LDL in the periphery
01:30:06.180 where you can measure it? And therefore is likely, even though their gradient is less
01:30:11.480 favorable, they might get more particles in there.
01:30:14.700 There was one randomized control trial. I think they fed soybean oil and saw oxidized LDL in
01:30:19.900 the periphery go up. But again, you're talking about like increasing from like, let's say,
01:30:24.860 and I'm making the numbers up, but it's on the order of, okay, normally maybe 0.5% is oxidized
01:30:30.060 and now it's 0.7, 0.8. That is such a small number compared to once a particle gets inside
01:30:37.400 the intima, the rate of oxidation can, I think the estimates I saw were anywhere from 30 to 80%
01:30:42.520 of those particles. And in fact, I actually had a long conversation with Tom Dayspring about this,
01:30:47.600 trying to understand it. Because if oxidized LDL in the periphery was really driving cardiovascular
01:30:53.900 disease, why have the studies where they give a bunch of antioxidants not decreased cardiovascular
01:30:59.160 disease? Because when we do that in animals, so they've actually done these studies, I think it's
01:31:04.100 in rabbits, where they'll put oxidized LDL into their bloodstream and they will see atherogenesis
01:31:11.220 progress. But when they do it with antioxidants, that doesn't happen. And that is because where most
01:31:17.360 of that oxidation is occurring is inside the intima. So your biggest lever to actually reduce
01:31:24.120 your overall amount of oxidized LDL is just to prevent as much getting into the intima and retained
01:31:30.920 as possible. And then when we look at people who have higher levels of oxidized LDL, it's typically
01:31:37.500 a downstream effect of how much LDL got into their intima in the first place. Because even after it gets
01:31:44.560 into the intima, retained for a while, oxidized, some of those oxidized molecules can still come
01:31:48.680 back out into the bloodstream. And so, yes, we do see people with greater amounts of cardiovascular
01:31:53.360 disease. Do we know if the oxidized LDL that we measure in the periphery was oxidized in the
01:32:00.560 periphery or is escaped LDL that was oxidized in the endothelial space? I don't know the exact answer
01:32:07.600 to that question because that would be difficult. You'd have to do some sort of metabolic tracer study.
01:32:12.120 Maybe you'd have to track it for a really long time, at least weeks to months to see if that
01:32:17.960 happens. I don't know for sure. I will attempt to answer the question as best I can. In people who
01:32:23.960 undergo myocardial infarctions, so where you have this kind of rupturing, they do see short-term
01:32:29.420 oxidized LDL go way up, coming out of the, presumably that's because it's coming out of the
01:32:34.920 intima since there's that rupture. But have they ever done a study to like kind of link it together
01:32:40.680 with like a stable isotope? I'm not sure about that. But again, I think the important point
01:32:46.560 is that the less ApoB that gets retained inside the intima, the less chance there is for overall
01:32:54.220 oxidation to occur. And really, aggregation is the endpoint that's much more important.
01:33:00.900 Oxidation is only bad, quote-unquote, because it's more prone to aggregate. But we know on balance
01:33:06.960 that saturated fat-enriched particles are more likely to aggregate than polyunsaturated-enriched
01:33:14.940 particles due to the differences in membrane fluidity, as well as the ability for ApoB to be
01:33:20.440 modified, and because of the sphingomyelin content and ceramide content of the saturated fat-enriched
01:33:26.840 molecules. So again, I would say, let's say I grant that those polyunsaturated fats per particle
01:33:32.820 more prone to oxidation. You're still having to weigh it against the other things that progress
01:33:37.840 cardiovascular disease. And on balance, you're still better off with the polyunsaturated fats
01:33:42.940 because they do lower the amount that gets into the intima. They lower the amount that gets retained
01:33:47.780 because it's less likely that ApoB will get enzymatically modified. And then those saturated
01:33:53.640 enriched particles, because they're rigid, because they produce ceramides, they're more likely to clump
01:33:57.500 together and cause that fatty streak and that lesion. Okay. So let's consider something else
01:34:02.960 though, which is for me to get a bottle of corn oil or any of the other seed oils on your table,
01:34:11.120 I have to do a lot of industrial processing. I have to heat these things up. I have to refine these oils.
01:34:18.380 I have to use industrial-grade solvents to extract them. It seems very likely that both of those
01:34:27.400 processes can contribute to the negative impact of them, independent of what we might see if we were
01:34:34.800 talking about something pure. In other words, everything we've talked about so far is assuming
01:34:39.020 a pure form of linoleic acid. But what if I'm now saying, yeah, but I'm going to heat, reheat, cool,
01:34:47.580 bastardize this molecule. And oh, by the way, I'm not going to be able to get all the hexane off this
01:34:52.220 molecule. And I needed to use hexane to extract it. We don't like to talk about it,
01:34:56.920 but food processing is big industrial chemistry. And what I would say is the actual processing
01:35:02.460 of the seed oils removes oxidants and removes some impurities that are maybe negative. There
01:35:10.540 are some things that do increase. We'll talk about that. But let's start with the hexane itself. So
01:35:16.060 to get the oils out of these seeds, you need to either do mechanical or chemical extraction.
01:35:21.400 Now, I think most people would say, well, I'd rather have the mechanical extraction, right? Because
01:35:25.320 less chemicals, but it is much more costly. The yield is lower and economics is a thing.
01:35:32.020 Is that an opportunity? Can you go into a grocery store and choose
01:35:35.240 to have safflower oil that was mechanically extracted versus chemically extracted?
01:35:40.720 I actually have no clue, but I would imagine there are probably places that do sell it.
01:35:43.960 Pay more for it?
01:35:44.780 For sure. For sure. So let's talk about why hexane is used. So they take these seeds,
01:35:48.460 they wash them with hexane. Why hexane? Well, hexane is a nonpolar solvent. And when you're
01:35:55.320 dealing with oil, polar solvents are much more popular because most things or most things that
01:36:00.940 we try to get are polar. Most things like to interact with water. It makes sense based on
01:36:04.540 our biology and our biochemistry. Oils are different. Oils you have to do very unique things to.
01:36:09.440 Hexane is a nonpolar solvent. So it will mix with these oils and it has a relatively low boiling
01:36:15.800 point. So you can evaporate it off. These seeds get washed with this hexane. It extracts the crude
01:36:23.060 oil. So now you've got the oil mixed with hexane. Well, now they bubble steam vapor through the oil
01:36:30.180 and that evaporates off the hexane. Now I will tell you that the steam and the temperature is
01:36:36.160 pretty low. In order to really start getting oxidation of seed oils, it depends on the oil
01:36:42.920 specifically. But most of them, you've got to be well over 200 degrees Celsius and you've got to
01:36:47.800 do it for hours. If we're talking about in like a large vat, I think I read like soybean oil, if you
01:36:53.520 heat it at like 240 degrees Celsius for like three hours, you will start to get a percent of the oil
01:37:01.280 being oxidized. But even after like five hours, it's still pretty small percentage points of
01:37:06.920 oxidation. And this process of removing the hexane is on the order of minutes or an hour,
01:37:12.380 90 minutes. Like it's a pretty short period of time. And hexane's boiling point is, I believe it's
01:37:17.820 69 degrees Celsius. So you only got to heat it up to a point a little bit above that to start getting
01:37:22.880 it off. Now, okay, can you get all of it off? Well, as anybody who's had basic chemistry, you know
01:37:28.440 that no compound you synthesize is 100% pure. I mean, you can get 99.999%, but you always have
01:37:35.800 residual atoms in there. You always have residual molecules in there. So the question becomes,
01:37:40.360 all right, how much hexane is in the end product and how much is required to cause harm? The hexane
01:37:46.160 in the end product, most of them are well under one part per million. In fact, a lot of them have
01:37:52.180 non-detectable levels of hexane, which means there's probably some in there, but the instruments
01:37:56.640 we have to measure it simply aren't sensitive enough to pick that out. So the amount of hexane in
01:38:03.300 these oils, I believe the research paper I read was anywhere from 0.05 to 0.5 parts per million for
01:38:11.640 most of these oils. Hexane specifically, the danger with hexane is not from ingestion. It's
01:38:18.060 actually from inhalation. So people who have had toxicity from hexane, it's from inhaling it.
01:38:24.480 When you actually look at how much hexane you'd have to get, I tried to look up hexane poisoning
01:38:29.380 cases where somebody died. It doesn't exist. There's a case where a guy drank, like literally
01:38:35.340 drank straight hexane and basically got a tummy ache. They've done rodent studies where they were
01:38:40.780 able to get toxicity and death, but basically just to get mild liver and neurotoxicity, it was 5,000
01:38:49.980 milligrams per kilogram of body weight. Now, when we do human equivalent dosage, that dosage becomes
01:38:57.100 smaller. But let me just put it in perspective as a bottom line. I did the calculation on this.
01:39:02.460 What you would need to consume from hexane to even have mild side effects, what you would need to
01:39:09.360 consume is 11,340 kilograms of oil at one time. Okay, but that's to die. No, that was for mild side
01:39:18.120 effects. Okay, but how do we know that the accumulation of hexane or some other industrial
01:39:24.020 solvent couldn't be leading to a chronic process? We've just talked about how all the diseases we
01:39:29.980 care about, whether it be neurodegenerative diseases or cancer or cardiovascular disease,
01:39:36.280 these things don't happen overnight. They don't happen in weeks, months, even years. Many times
01:39:40.720 they happen in decades. And so if we're talking about a lifetime exposure to these things, how do
01:39:44.800 we know that that's not increasing our risk? When we talk about lifetime exposure from something
01:39:49.180 like LDL, that's a relatively high concentration in our bloodstream. And it's always present. You
01:39:55.160 always have a baseline level of LDL. You don't really have baseline levels of hexane in your
01:39:58.920 bloodstream, I don't think, at least not to any appreciable level. And there is a process through
01:40:04.720 your body where your body converts this to something innocuous and gets rid of it. So really,
01:40:09.520 when it comes to things that don't, what we call bioaccumulate, the question is, if we have some of
01:40:15.100 this, is it in an amount that can be cleared quickly enough to where there's not negative
01:40:19.120 outcomes? And what I would say is, okay, the example I gave was the amount of oil you'd need
01:40:23.880 to consume to possibly get mild side effects. If anybody wants to, okay, say, let's just say your
01:40:30.880 body couldn't process this out. Who's drinking 11,000 kilograms of oil in their lifetime? I think
01:40:36.920 probably almost no one. So I just don't see the possibility for hexane having a negative outcome
01:40:44.180 for people, especially when you consider that it's a very, very low concentration. It doesn't
01:40:49.760 bioaccumulate and your body has a way to process it out. And the amounts that you get are incredibly
01:40:55.060 small from these seed oils. Okay. Now let's consider the fact that about a hundred years ago,
01:41:01.880 less than 3% of total food availability was made up of linoleic acid. Today, that number is,
01:41:09.560 I mean, it's probably closer to 10%. What I read, because I actually read a book that was
01:41:15.660 anti-seed oil because I was trying to understand the arguments. The figure they quoted was a 75X
01:41:21.440 increase in linoleic acid over the last like 150 years or so. Okay. That's even more than what I've
01:41:27.420 got. So that's an enormous increase. Huge. To make it even more stark, this means that we did not
01:41:33.820 evolve in an environment where people were consuming seed oils in much quantity at all.
01:41:39.000 And yet today, people are probably getting 10 to 15% of their total calories from these things,
01:41:45.500 right? Some people do. Yeah, for sure. And tissue levels are up more than a hundred percent.
01:41:51.380 Yep. Isn't there just sort of a first principles argument to be made here that says,
01:41:56.180 how would that be a good thing? How would that be anything but negative?
01:42:01.200 Yeah. And this kind of gets back to the, we're starting to tie into the naturalistic argument.
01:42:06.480 So what I will say is, again, you have to be logically symmetrical with how you approach these
01:42:10.380 things. And even people who think they eat natural these days, the human diet now is not in any way,
01:42:16.980 shape, or form what it used to be. So people will point out, well, look at how these vegetables and
01:42:21.480 fruits and plants have been modified. Yeah, but we've done the exact same thing to our animals.
01:42:25.360 If you think having a fatty ribeye is a ancestral diet, it's not. Those cows are much different
01:42:34.020 than they used to be. And it's not wild game. These are very different things. Take that out
01:42:40.120 of it for a moment though. Try to really zoom out and think about what is the purpose of biology?
01:42:45.900 The purpose of biology is to pass on your genetic material. So when it comes to survival and longevity,
01:42:52.720 and I'm sure you're very well familiar with this, there's a reason things start to kind of go
01:42:56.660 downhill after like age 40 or whatever. It's because you're past breeding age. Evolution's
01:43:01.380 done with you. You've done what you can do. You've passed on your genetic material. Hopefully you can
01:43:05.080 stay around a little bit longer to raise the next generation, but you've done your job.
01:43:08.920 The idea of longevity, living a very long life, that's not really something that's essential to a
01:43:16.820 species surviving or even thriving. Some of the most prevalent species on the planet don't live
01:43:23.660 very long. What matters is that they get to pass on their genetic material, that the favorable traits
01:43:28.540 are passed on in the genetic material. When it comes to cardiovascular disease, yes, rates of
01:43:34.720 cardiovascular disease have gone up because you actually have the chance to get cardiovascular disease
01:43:38.980 now because you're not killed by a virus or you're not killed by a warring tribe or you're not killed
01:43:44.840 by bacteria. Even if we go back into the 1860s, this book I read, one of the things that said was
01:43:52.320 cardiovascular disease is a 20th century disease. Didn't exist before that. No, it existed. People
01:43:57.700 just fell over dead and nobody knew why. And for the most part, people didn't have much chance to get
01:44:04.620 cardiovascular disease. I think you, forgive me if I'm wrong, but you stated basically if you live long
01:44:10.260 enough, everyone at some point will get some form of cardiovascular disease. It's just a time and
01:44:15.800 exposure issue as we talked about. This massive increase in cardiovascular disease, which, oh, by the
01:44:20.800 way, I point out that everyone lives longer now. I don't know if it dipped recently, but I think we're
01:44:24.720 still right around like the longest age lived on average. The point being, even in the 1860s,
01:44:30.980 if you live past age 10, I think your average life expectancy was still something like 55 to 60
01:44:38.160 years old. So most people didn't have the chance to get cardiovascular disease or they died from
01:44:43.640 something else. And again, I mean, this is back when we used to bleed people to try and treat them, get rid of
01:44:49.400 the toxic blood. We didn't have the tools to understand what we were looking at. This is one of those arguments
01:44:54.480 that people, when they say, well, everybody's sicker now, we're more unhealthy now. That's true. That is true.
01:45:00.460 But part of that is we just have had the chance to get unhealthy. And evolutionarily, I will also say
01:45:07.720 we're taking one step out like we do with the MR studies. But LDL cholesterol, high LDL cholesterol
01:45:13.020 is not ancestral. If we look at the best estimate we have of what our ancestors did, which is the
01:45:19.240 Hadza, which are basically a tribe that are essentially untouched by humanity. We have studied
01:45:24.780 them quite a bit because this is our best guess as to what ancestral was. The foods they eat,
01:45:32.040 it's about as untouched as you can get. If you look at the LDL of the Hadza, who have very low rates of
01:45:38.480 almost non-existent rates of cardiovascular disease, they're 50 to 70 on average. I think they even had
01:45:45.460 one Hadza who was like under 30. I think they only found one Hadza individual who is over 100 LDL.
01:45:53.640 I would argue, again, we're not talking about linoleic acid, obviously, but we do know that
01:45:57.700 linoleic acid lowers LDL. I would argue that what the anti-seed oil people would suggest should be an
01:46:06.120 ancestral diet is not supported by the evidence either. And so regardless, there's a reason naturalism
01:46:12.760 has its own fallacy associated with it. Because you can find a lot of things in nature that are
01:46:17.620 horrific toxins. You can find a lot of synthetic things that are quite good for you. And so I think
01:46:24.440 we tend to romanticize the past on every single level, right? Like we romanticize past relationships,
01:46:31.240 we romanticize like 50 years ago, things were so much better, there was less crime. And then when you
01:46:35.420 actually go pull up the FBI statistics, it's not even close. Crime is way lower now. But we romanticize
01:46:41.080 the past. And we romanticize how things used to be. And what I would say is that I don't think what
01:46:47.180 we think might be natural is necessarily a good barometer for what is conducive to living the
01:46:53.940 longest, healthiest life. I think you're kind of getting the order reversed. Mankind evolved in this
01:47:00.840 environment where I think one of the reasons we were able to thrive is we were some of the most
01:47:05.120 adaptable creatures out there. Obviously, smarter as well. But being so adaptable to our environment
01:47:11.180 helped us greatly. Because we used to think, well, the strongest survive. And really, we know it's
01:47:16.600 actually the animals that are most adaptive survive. So when we look at all the data together,
01:47:23.060 the question really shouldn't be, did we evolve eating seed oils? Or did we evolve eating this?
01:47:28.940 The question should be, based on the best evidence we have,
01:47:32.140 what is the overall net effect of these things? And I mean, again, like we were talking about the
01:47:37.560 processing earlier, I'll just run through a few more things. They say, you know, sodium hydroxide
01:47:41.600 gets used. There's very little of that in the end product. Activated clay gets used. Basically,
01:47:48.680 if we look at these things, the amounts that you would need to consume of this oil, and these are all
01:47:54.500 theoretical negative effects, assuming that, for example, pure sodium hydroxide stays in the end
01:47:58.620 component, which we know, it basically turns into soap and water. When you have a
01:48:01.980 chemical reaction, but even if the amount you put in stayed in there till the end, you still need
01:48:08.100 to eat two to 700 kilograms at one time of the oil. When we look at the end product of the oil
01:48:17.160 manufacturing process, it actually decreases the amount of oxidated. So there's a measure that can
01:48:22.540 use like a peroxide status to look at how much is in there. It goes down by a factor of about five to
01:48:27.820 tenfold. And then another measurement of like the aldehyde amount in the crude oil versus the actual
01:48:34.080 refined oil is much lower. Now, you do have, I think, polymerized trisoglycerides increase a little
01:48:41.220 bit. You do have some trans fats formation during this process. It's about 0.5% of the oil, but they're
01:48:47.080 all so low that it's very far below the threshold of what would cause negative effects. Now, there's no
01:48:52.740 safe amounts of trans fats, but again, we're taking this on balance. If we have this refined oil with a
01:48:58.740 very small amount of trans fat, but we know it lowers LDL so much, and then we have all the other
01:49:04.600 mechanistic data, what we call the converging lines of evidence, the mechanism is clearly elucidated.
01:49:10.760 The cohort trials agree with it. And then the studies that are not confounded by massive amounts of
01:49:16.160 trans fats agree. The Mendelian randomization trials agree. I guess the one other point I would
01:49:22.660 make is linoleic acid and polyunsaturated fats. When we trade them out in a one-to-one ratio for
01:49:28.800 saturated fat, they either have neutral or positive effects on inflammation, liver fat, insulin
01:49:36.160 sensitivity, and overall metabolic health. And that's been very clearly shown in numerous studies.
01:49:41.860 So again, if we boil down to it, regardless of what we think was an ancestral diet, which we don't
01:49:47.420 even know if that's necessarily the healthiest diet on balance, if you're going to make the argument
01:49:52.840 that polyunsaturated fats are bad, you have to be okay with the argument that saturated fat is really,
01:49:57.340 really bad. Okay. So how do we land this plane for folks? If you're out there and you're trying to
01:50:02.640 make sense of social media, you know, it's sort of funny. I was out at a restaurant recently and the
01:50:08.700 menu made a point to say there were no seed oils used in the preparation of the food.
01:50:14.480 So this is clearly a part of the popular zeitgeist. I'm pretty sure that the chef at that restaurant
01:50:21.420 isn't familiar with a single argument that has been made here today. So we're talking about an
01:50:28.360 argument that has sort of transcended a scientific discussion. So seed oils are culturally persona
01:50:36.520 non grata. The question is, is that warranted? You have, I think, fairly convincingly argued,
01:50:44.320 no. So for the individual listening to us, is there a precautionary principle? If someone says,
01:50:51.020 you know what, Lane, I've heard everything you've said. I can't poke holes in it, but why should I go
01:50:55.640 out and eat seed oils? What would you say to that person? I would say, okay, if you don't want to
01:51:00.960 consume seed oils, fine. But find something to displace the saturated fat in your diet with.
01:51:06.700 So leaner cuts of proteins, of meats, lower saturated fat sources of protein. And I guess
01:51:14.960 while monounsaturated fats don't seem to have the same effect on LDL cholesterol as polyunsaturated
01:51:21.360 fats, they do lower it when exchanged for saturated fats. They do appear to be cardioprotective to a
01:51:26.620 certain extent. It doesn't appear to be as cardioprotective as polyunsaturated fats. But if you are concerned
01:51:32.200 and you're not going to listen to logic that we've laid out here for three hours, then okay, try and
01:51:38.020 find some monounsaturated fats. So like olive oil, avocado oil, there's other sources of oils that you
01:51:44.820 could use that are still relatively cardioprotective or beneficial. And I didn't point this out when
01:51:52.380 talked about the processing. It should be pointed out that this is unique in that when these oils
01:51:56.820 are in a large volume, the rate of oxidation is low, even with heating. By the way, all the heating
01:52:01.980 in the processing of these oils is done under a vacuum, which means there's no oxygen, which means
01:52:07.880 virtually no chance for oxidation, even when heated. In restaurants, however, when you are frying
01:52:14.200 something, especially if you are frying in a thin layer of oil, the research shows going from like a,
01:52:20.300 I want to say it's like a one centimeter to like five centimeters of oil, huge difference in how
01:52:26.740 quickly oxidized and negative products will start to form. And if you are having oil that you are
01:52:34.540 frying, refrying in over and over and over, yes, certainly with a thin layer within 20, 30 minutes,
01:52:41.160 you can start to have significant amounts of these negative products accumulating. And then if you have
01:52:46.060 it in a vat and it's being heated all day, yeah, you're probably gonna have a significant amount of
01:52:50.020 oxidized, trans fats.
01:52:52.520 So would we be better off when it comes to heating oil using lard? In other words,
01:52:57.580 if I'm gonna have French fries, should I at least have my French fries made in lard as opposed to
01:53:02.220 polyunsaturated fat and seed oil?
01:53:04.020 So here's what I'd say. Both are bad.
01:53:06.320 Let's just say, I understand that French fries are hypercaloric, and let's just put that aside.
01:53:11.600 I'm gonna have French fries sometimes. So when I do, do I want McDonald's going back to
01:53:17.080 lard, or do I want them sticking with whatever seed oil they're using?
01:53:22.080 That's kind of a hard question to answer, right? Because you have competing mechanisms at play here.
01:53:27.560 And if we don't have a human RCT looking at frying with one way versus frying with another way,
01:53:33.160 and I'm not aware of any, but maybe there will be some, maybe a young potential scientist listening
01:53:37.960 to this would want to do this. But looking at, okay, what happens with LDL and then the components
01:53:42.820 of LDL?
01:53:43.820 But you're answering this purely through an LDL lens.
01:53:47.040 Right, right, right.
01:53:47.680 Yeah. Is there any other reason to care? It just feels to me intuitively that at least when you
01:53:53.860 heat up the saturated fat, you're less likely to introduce more ROS and other things. And by the
01:54:00.080 way, if I can control my LDL through other means pharmacologically, do I really care about my
01:54:04.420 saturated fat consumption?
01:54:05.820 We'll touch on that here in a second. So yeah, the saturated fat's less prone to oxidation.
01:54:09.820 Again, when we're looking at balance, what's going to negatively affect cardiovascular disease the
01:54:14.140 most? I don't know. What I would say is, if you're going to have french fries, just have the french
01:54:19.800 fries. If you want to have it fried in lard, okay, fine, whatever. You can decide what you want to do.
01:54:24.920 You're basically saying, don't treat my fries in lard as health food.
01:54:27.840 No. That's actually a really important point you bring up. You have to understand, people think
01:54:32.580 food companies care about which foods you buy. They just want you to buy. And so the pivot to,
01:54:38.460 oh, we're going to have tallow or lard or whatever. Food companies don't care. It's okay. Well,
01:54:43.740 we'll just make those then. That's fine. Oh, you don't like red dye 40? Yeah, we'll take that out.
01:54:48.320 And then we'll market about how healthy our cereal is now. We're marketing how healthy our french fries
01:54:53.120 are. The danger becomes, this really only becomes a problem if you're consuming french fries pretty
01:54:58.500 regularly. And then we have to ask the question, all right, which is worse out of these two really bad
01:55:03.660 options. But when you're marketing as some kind of victory that, okay, we're using beef
01:55:09.400 towel or using lard or whatever it is, as opposed to seed oils. If you're not having this sort of
01:55:14.800 communication, people, what they're going to interpret that as is, oh, these are actually
01:55:20.440 healthier now. I can eat more of them. I think that's one thing I've realized as being so in tune
01:55:25.860 with the public and reading comments on social media over years and years and years. I realized how if
01:55:30.500 I'm not extremely careful with how I word things, how misinterpreted it can get. I think as
01:55:37.520 communicators, like in a format like this, this is great. And when you say like, how do people navigate
01:55:43.120 on social media? That's where it's really tough because it's not this, right? It's 30 seconds.
01:55:48.240 How can I hook somebody in? Five reasons why seed oils are toxic. That's going to get a lot of attention.
01:55:54.020 And they're going to list things that there is an element of truth to every single thing that they
01:56:00.380 say. But they are leaving out all of the context that we just put multiple hours into covering.
01:56:07.100 I mean, I hope this podcast gets listened to by hundreds of millions of people, but the likelihood
01:56:10.540 is pretty unlikely. What's more likely is somebody puts up a TikTok and it goes viral and 10 million
01:56:15.680 people see it. I think it's very difficult to communicate this stuff with the public. To them,
01:56:22.780 there are so many mixed messages. Peter, I hear this all the time where people say,
01:56:27.980 you know, I don't trust scientific research because one study says this and one study says
01:56:31.540 that and they all contradict each other. And what I say to people is I say, did you actually read the
01:56:36.660 study or are you just looking at the social media hot takes? Because my guess is you're probably
01:56:41.500 looking at the hot takes. Because what we just did going into those studies, when they seemingly have
01:56:46.700 a weird outcome, I can tell you almost any time, 99% of the time, when I've seen a headline or a
01:56:52.620 social media hot take on a study that I go, that doesn't make sense. And then I go and read the
01:56:57.740 actual study. 99 times out of 100, I walk out going, oh, okay, I see why they found what they
01:57:02.720 found. Either the way the control group was designed or the difference in levels between
01:57:08.260 groups or whatever. My PhD advisor used to say, if I wanted to design a study to show no effect
01:57:13.540 or the study to show an effect, easiest thing in the world. And so again, this is why we look at
01:57:18.940 converging lines of evidence. We look at what does all the evidence state and what do the most
01:57:24.160 high quality, most rigorously controlled studies find? Yes, there are elements of truth to the
01:57:31.040 criticisms of seed oils. But on balance, when we look at these hard outcomes, when we look at what
01:57:37.260 we are very sure we know to be true, I think one of the things to point out in science, you can never
01:57:42.180 prove anything, right? We can only disprove things. But we can have relative degrees of confidence in
01:57:47.720 various data. I would say I have a relatively high degree of confidence that ApoB-containing
01:57:54.360 lipoproteins are atherogenic. Based on everything I've read, the converging lines of data,
01:58:00.920 especially the Mendelian randomization studies, especially the statin trials,
01:58:04.940 I feel relatively confident about it. Could I change my mind? Sure, but it would take a lot of
01:58:09.180 data over a long period of time. Now, you asked one question that I want to circle back to.
01:58:14.240 Why care about nutrition if you can just control this with statins?
01:58:16.600 No, that was in the context, I think, of why care about the effect on LDL if you can
01:58:22.120 pharmacologically regulate that anyway? And therefore, should we be focused on other negative
01:58:27.440 health benefits in the case of the frying? That was really my question.
01:58:30.620 Oh, I see what you're saying. So let's take care of the LDL piece, and then now oxidation or
01:58:35.460 aldehydes or whatnot become more important.
01:58:37.440 I was asking that specifically in the context of the frying oils.
01:58:40.200 That makes sense, yeah.
01:58:41.080 And cooking.
01:58:41.480 Yeah, I don't have a great answer for that, because I think one of the other frustrations
01:58:45.620 with the general public is when we put out limitations of studies, you and I know, we're
01:58:51.680 not necessarily saying, hey, these researchers are idiots. They did it wrong. They should
01:58:55.540 have done it this way. Every study has limitations. Every single study that's ever been done in
01:58:59.920 the history of mankind. There is no unifying study that explains the entire universe.
01:59:04.100 So pointing out limitations is not necessarily saying that a study is bad. It's just pointing
01:59:11.060 out, okay, we got to be careful how much interpretation we give to this, how broadly we
01:59:16.240 interpret it. And yes, there are studies that are more well-designed, well-conducted, that
01:59:21.560 have more statistical power, that have better measurements. And scientists try to account
01:59:27.080 for that when they look at, okay, how much weight am I going to give to something? But again,
01:59:31.940 at the end of the day, if I have to give a recommendation for people on this stuff, I would
01:59:37.160 say, when it comes to seed oils, if you don't want to consume them, okay. I would just say,
01:59:41.740 try to limit your saturated fat, eat enough fiber. But outside of that, there's so many
01:59:47.180 bigger levers that you can pull for your health than just worrying about seed oils. Put up a
01:59:52.560 thing a while back, I said, the average calorie consumption in the United States is 3,500 calories
01:59:59.020 per day. And the average physical activity is less than 20 minutes per day. You're spending
02:00:03.520 all this time worrying about what your fries get fried in. Not you specifically, but just
02:00:07.700 people in general. We're stepping over $100 bills, picking up pennies. Again, I'm not saying
02:00:13.300 don't worry about the little stuff, but you got to keep it in context of what really is driving
02:00:18.900 so much disease in the developed countries. A lot of it really is an energy toxicity issue.
02:00:25.940 Just to put a final bow on this, if you're looking at the macro trend of declining health
02:00:32.120 in the last 50 years, you're going to argue that caloric imbalance and activity levels are
02:00:39.600 contributing how much more than increasing seed oils? A little bit more, a lot more, medium
02:00:46.700 more?
02:00:47.120 I would say a lot more. Here's why I come to that. So there's no direct comparisons. I'm
02:00:52.380 going to say it right now. I'm going out on a limb. These are tenuous assertions by me,
02:00:57.740 my opinion. You look at the hazard ratios for mortality, talking about obesity. You're
02:01:02.860 not talking about, we're talking about like class three, class four obesity, even with
02:01:07.540 healthy blood markers, healthy obesity. You're not talking about 20, 30%. You're talking about
02:01:13.460 80 to 200%. You're talking about massive increases in the risk of mortality. When you're talking
02:01:19.260 about things like exercise, I mean, you talk about this all the time, your strength, your
02:01:25.460 lean mass, your activity levels, enormous predictors of how long you will live to the
02:01:32.880 order of hundreds of percentage points of magnitude when it comes to VO2 max, grip strength, overall
02:01:39.080 strength. I don't think there's anything unique about grip strength. It's just a proxy for overall
02:01:42.700 strength. And so again, that's not to say, hey, if you can make adjustments that make a
02:01:48.400 benefit overall, I don't want to be a whataboutism person either, but just make sure that your time
02:01:54.780 effort is being spent in your mind space. I got that from you. I liked what you said about that.
02:01:59.540 Your mind space is being spent on the things that will move the lever the biggest. And okay,
02:02:05.140 so you're controlling your caloric intake. You're exercising regularly. You don't want to eat seed
02:02:09.500 oils. Cool. Don't eat them. But I would also say, try to limit your saturated fat as well.
02:02:14.900 And try to make sure your LDL is under control. Get your APOB measured. I mean,
02:02:19.780 these are things that are modifiable. So if you can modify them, why not? And the last thing I will
02:02:24.100 say, because people do this too, I am not saying, and I don't think that you would say that APOB and
02:02:30.120 LDL are the only things that drive cardiovascular disease. Blood pressure, cardiovascular fitness,
02:02:38.140 insulin sensitivity, inflammation, these things all matter. They all matter. We are just saying,
02:02:43.340 and I'll give an example. You could have high LDL, but every other factor is low and your overall
02:02:48.900 risk for cardiovascular disease might be low. You can have high LDL and you might live to 90,
02:02:54.940 100 years old. That can happen. But there's also people who smoke for long periods of time and live
02:03:00.540 to be old. That doesn't mean that you should smoke or that it's not negative because statistics are just
02:03:07.500 probabilities. These are just probabilities. These are not hard. This is definitely going to happen.
02:03:12.760 So of course, you can always find an individual to show a difference. But all we are saying,
02:03:18.840 or all I am saying, is that everything else being equal, having your LDL lower is better,
02:03:24.960 all things being equal to having it higher.
02:03:27.780 All right. Well, Lane, I think that kind of brings this discussion to an end. I don't think this was
02:03:32.680 necessarily as interesting as it would have been in its original format, where we could have done it
02:03:38.560 as a genuine two-person point of view. I tend to agree with the point of view you've put forth.
02:03:44.500 My own nomenclature on this is that we're majoring in the minor and minoring in the major. I just don't
02:03:49.320 think this matters all that much, frankly. And my lack of enthusiasm around this topic is probably
02:03:54.700 palpable. I also think I'd make one final point to what you said, which is there is another confounder
02:04:01.220 with seed oils, which is that they tend to show up in low quality foods. And therefore, if you make
02:04:07.240 the decision to restrict your seed oils, you are probably doing a net benefit to yourself because
02:04:12.680 you are simply going to eat less Oreos, less potato chips, less junky salad dressings, and crappy
02:04:22.340 sauces and things like that. So the substitution effect will probably work in your favor, but you
02:04:29.460 don't have to be maniacal. If, for example, when you're making a salad, you prefer the taste of
02:04:35.820 safflower oil or canola oil over olive oil, it doesn't seem like you're killing yourself by doing
02:04:41.360 it based on the data. And you probably don't need to go to restaurants that are adamant that they
02:04:47.540 exclude seed oils because if it's a good restaurant, whether it uses seed oils or not, it's probably
02:04:52.220 using good ingredients otherwise, and you're probably going to be just fine. Yeah. I mean, you make a
02:04:57.660 great point about, it's probably more about what comes along for the ride. Another comparator real
02:05:02.100 quick, like sugar intake. People cut out sugar and they say, well, I felt better. You cut out a bunch
02:05:07.720 of junk food, but then you have people who get maniacal with it and start cutting out fruit
02:05:12.020 because fruit has sugar. Biochemically, it's basically the same thing. Once it gets in your
02:05:16.440 body, now there's a bridge too far. And I would argue the same thing that I think most people who are
02:05:22.140 experiencing negative effects from seed oils just have an overall probably low quality diet.
02:05:27.500 This isn't a problem for people who are going, you know, I think I'm going to cook with some canola
02:05:32.000 oil today and maybe use a seed oil-based solid dressing here and there. I think that that's
02:05:39.240 probably not what's happening. And what is happening is people are eating a lot of potato chips,
02:05:47.140 french fries, whatnot. And then the kind of anti-establishment people come out and they
02:05:51.920 say, look at how much our seed oil intake has increased. And we did what the government told
02:05:55.480 us to. Yeah. So my only wish that come from this podcast, in addition to public education,
02:05:59.940 is if you are a restaurateur and you're listening to this, please take the no seed oils used off your
02:06:05.580 menu. It insults me and it insults anybody who's been patient enough to listen to this episode.
02:06:12.380 So with that, thank you. Yeah. Thanks for having me. This was fun and a really cool
02:06:16.420 educational experience. I loved it. So thank you for having me and let me rap about this stuff for
02:06:22.340 a couple hours. Thank you for listening to this week's episode of The Drive. Head over to
02:06:27.920 peteratiyamd.com forward slash show notes. If you want to dig deeper into this episode,
02:06:34.740 you can also find me on YouTube, Instagram, and Twitter, all with the handle peteratiyamd.
02:06:40.340 You can also leave us review on Apple podcasts or whatever podcast player you use.
02:06:45.580 This podcast is for general informational purposes only and does not constitute the practice of
02:06:50.860 medicine, nursing, or other professional healthcare services, including the giving
02:06:54.700 of medical advice. No doctor patient relationship is formed. The use of this information and the
02:07:01.020 materials linked to this podcast is at the user's own risk. The content on this podcast is not intended
02:07:07.040 to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or
02:07:12.980 delay in obtaining medical advice from any medical condition they have, and they should seek the
02:07:17.640 assistance of their healthcare professionals for any such conditions. Finally, I take all conflicts
02:07:23.280 of interest very seriously. For all of my disclosures and the companies I invest in or advise, please
02:07:29.180 visit peteratiyamd.com forward slash about where I keep an up-to-date and active list of all disclosures.